PD Review References for 2006:

1: Verdaguer E, Susana Gde A, Clemens A, Pallàs M, Camins A.
Implication of the transcription factor E2F-1 in the modulation of neuronal
apoptosis.
Biomed Pharmacother. 2007 Aug;61(7):390-9. Epub 2006 Nov 29. Review.
PMID: 17178208 [PubMed - indexed for MEDLINE]

2: Ellrichmann G, Russ H, Müller T.
[Dyskinesia in Parkinson's disease--major clinical features, aetiology, therapy]
Fortschr Neurol Psychiatr. 2007 Jul;75(7):387-96. Epub 2006 Nov 17. Review.
German.
PMID: 17443441 [PubMed - indexed for MEDLINE]

3: Lee JY, Deogaonkar M, Rezai A.
Deep brain stimulation of globus pallidus internus for dystonia.
Parkinsonism Relat Disord. 2007 Jul;13(5):261-5. Epub 2006 Nov 1. Review.
PMID: 17081796 [PubMed - indexed for MEDLINE]

4: Jöbges EM, Spittler-Schneiders H, Renner CI, Hummelsheim H.
Clinical relevance of rehabilitation programs for patients with idiopathic
Parkinson syndrome. II: Symptom-specific therapeutic approaches.
Parkinsonism Relat Disord. 2007 May;13(4):203-13. Epub 2006 Oct 20. Review.
PMID: 17055766 [PubMed - indexed for MEDLINE]

5: Jöbges M, Spittler-Schneiders H, Renner CI, Hummelsheim H.
Clinical relevance of rehabilitation programs for Parkinson's disease. I:
Non-symptom-specific therapeutic approaches.
Parkinsonism Relat Disord. 2007 May;13(4):195-202. Epub 2006 Oct 20. Review.
PMID: 17055765 [PubMed - indexed for MEDLINE]

6: Falnes PØ, Klungland A, Alseth I.
Repair of methyl lesions in DNA and RNA by oxidative demethylation.
Neuroscience. 2007 Apr 14;145(4):1222-32. Epub 2006 Dec 18. Review.
PMID: 17175108 [PubMed - indexed for MEDLINE]

7: Zeng X, Rao MS.
Human embryonic stem cells: long term stability, absence of senescence and a
potential cell source for neural replacement.
Neuroscience. 2007 Apr 14;145(4):1348-58. Epub 2006 Oct 19. Review.
PMID: 17055653 [PubMed - indexed for MEDLINE]

8: Lobbezoo F, Naeije M.
Dental implications of some common movement disorders: a concise review.
Arch Oral Biol. 2007 Apr;52(4):395-8. Epub 2006 Nov 27. Review.
PMID: 17125732 [PubMed - indexed for MEDLINE]

9: Foxton RH, Land JM, Heales SJ.
Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease;
potential pathogenic mechanisms.
Neurochem Res. 2007 Apr-May;32(4-5):751-6. Epub 2006 Dec 27. Review.
PMID: 17191137 [PubMed - indexed for MEDLINE]

10: Constantinescu R, Leonard C, Deeley C, Kurlan R.
Assistive devices for gait in Parkinson's disease.
Parkinsonism Relat Disord. 2007 Apr;13(3):133-8. Epub 2006 Aug 17. Review.
PMID: 16914362 [PubMed - indexed for MEDLINE]

11: Shahed J, Jankovic J.
Exploring the relationship between essential tremor and Parkinson's disease.
Parkinsonism Relat Disord. 2007 Mar;13(2):67-76. Epub 2006 Aug 2. Review.
PMID: 16887374 [PubMed - indexed for MEDLINE]

12: Bonsi P, Cuomo D, Picconi B, Sciamanna G, Tscherter A, Tolu M, Bernardi G,
Calabresi P, Pisani A.
Striatal metabotropic glutamate receptors as a target for pharmacotherapy in
Parkinson's disease.
Amino Acids. 2007 Feb;32(2):189-95. Epub 2006 May 22. Review.
PMID: 16715415 [PubMed - indexed for MEDLINE]

13: Ossowska K, Konieczny J, Wardas J, Pietraszek M, Kuter K, Wolfarth S, Pilc A.
An influence of ligands of metabotropic glutamate receptor subtypes on
parkinsonian-like symptoms and the striatopallidal pathway in rats.
Amino Acids. 2007 Feb;32(2):179-88. Epub 2006 May 15. Review.
PMID: 16699817 [PubMed - indexed for MEDLINE]

14: Friedl KE, Grate SJ, Proctor SP, Ness JW, Lukey BJ, Kane RL.
Army research needs for automated neuropsychological tests: monitoring soldier
health and performance status.
Arch Clin Neuropsychol. 2007 Feb;22 Suppl 1:S7-14. Epub 2006 Nov 28. Review.
PMID: 17127031 [PubMed - indexed for MEDLINE]

15: Kane RL, Roebuck-Spencer T, Short P, Kabat M, Wilken J.
Identifying and monitoring cognitive deficits in clinical populations using
Automated Neuropsychological Assessment Metrics (ANAM) tests.
Arch Clin Neuropsychol. 2007 Feb;22 Suppl 1:S115-26. Epub 2006 Nov 13. Review.
PMID: 17101258 [PubMed - indexed for MEDLINE]

16: Joyce JN, Millan MJ.
Dopamine D3 receptor agonists for protection and repair in Parkinson's disease.
Curr Opin Pharmacol. 2007 Feb;7(1):100-5. Epub 2006 Dec 13. Review.
PMID: 17174156 [PubMed - indexed for MEDLINE]

17: Frieling H, Hillemacher T, Ziegenbein M, Neundörfer B, Bleich S.
Treating dopamimetic psychosis in Parkinson's disease: structured review and
meta-analysis.
Eur Neuropsychopharmacol. 2007 Feb;17(3):165-71. Epub 2006 Oct 27. Review.
PMID: 17070675 [PubMed - indexed for MEDLINE]

18: Borta A, Höglinger GU.
Dopamine and adult neurogenesis.
J Neurochem. 2007 Feb;100(3):587-95. Epub 2006 Nov 13. Review.
PMID: 17101030 [PubMed - indexed for MEDLINE]

19: Raule N, Sevini F, Santoro A, Altilia S, Franceschi C.
Association studies on human mitochondrial DNA: methodological aspects and
results in the most common age-related diseases.
Mitochondrion. 2007 Feb-Apr;7(1-2):29-38. Epub 2006 Dec 5. Review.
PMID: 17306632 [PubMed - indexed for MEDLINE]

20: Fukae J, Mizuno Y, Hattori N.
Mitochondrial dysfunction in Parkinson's disease.
Mitochondrion. 2007 Feb-Apr;7(1-2):58-62. Epub 2006 Dec 13. Review.
PMID: 17300997 [PubMed - indexed for MEDLINE]

21: Halpern C, Hurtig H, Jaggi J, Grossman M, Won M, Baltuch G.
Deep brain stimulation in neurologic disorders.
Parkinsonism Relat Disord. 2007 Feb;13(1):1-16. Epub 2006 Dec 1. Review.
PMID: 17141550 [PubMed - indexed for MEDLINE]

22: Alex KD, Pehek EA.
Pharmacologic mechanisms of serotonergic regulation of dopamine
neurotransmission.
Pharmacol Ther. 2007 Feb;113(2):296-320. Epub 2006 Oct 17. Review.
PMID: 17049611 [PubMed - indexed for MEDLINE]

23: Geraerts M, Krylyshkina O, Debyser Z, Baekelandt V.
Concise review: therapeutic strategies for Parkinson disease based on the
modulation of adult neurogenesis.
Stem Cells. 2007 Feb;25(2):263-70. Epub 2006 Nov 2. Review.
PMID: 17082225 [PubMed - indexed for MEDLINE]

24: Fishel ML, Vasko MR, Kelley MR.
DNA repair in neurons: so if they don't divide what's to repair?
Mutat Res. 2007 Jan 3;614(1-2):24-36. Epub 2006 Aug 1. Review.
PMID: 16879837 [PubMed - indexed for MEDLINE]

25: Dhandapani KM, Brann DW.
Role of astrocytes in estrogen-mediated neuroprotection.
Exp Gerontol. 2007 Jan-Feb;42(1-2):70-5. Epub 2006 Jul 26. Review.
PMID: 16872778 [PubMed - indexed for MEDLINE]

26: Bandhyopadhyay U, Cuervo AM.
Chaperone-mediated autophagy in aging and neurodegeneration: lessons from
alpha-synuclein.
Exp Gerontol. 2007 Jan-Feb;42(1-2):120-8. Epub 2006 Jul 24. Review.
PMID: 16860504 [PubMed - indexed for MEDLINE]

27: Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J.
Free radicals and antioxidants in normal physiological functions and human
disease.
Int J Biochem Cell Biol. 2007;39(1):44-84. Epub 2006 Aug 4. Review.
PMID: 16978905 [PubMed - indexed for MEDLINE]

28: Fuxe K, Canals M, Torvinen M, Marcellino D, Terasmaa A, Genedani S, Leo G,
Guidolin D, Diaz-Cabiale Z, Rivera A, Lundstrom L, Langel U, Narvaez J,
Tanganelli S, Lluis C, Ferré S, Woods A, Franco R, Agnati LF.
Intramembrane receptor-receptor interactions: a novel principle in molecular
medicine.
J Neural Transm. 2007 Jan;114(1):49-75. Epub 2006 Oct 27. Review.
PMID: 17066251 [PubMed - indexed for MEDLINE]

29: Archer T, Beninger RJ.
Movement disorders: neurodevelopment and neurobehavioural expression.
J Neural Transm. 2007;114(4):XXXIII-XLI. Epub 2006 Oct 6. Review.
PMID: 17024325 [PubMed - indexed for MEDLINE]

30: Antonelli T, Tomasini MC, Fuxe K, Agnati LF, Tanganelli S, Ferraro L.
Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2
interactions in the basal ganglia.
J Neural Transm. 2007 Jan;114(1):105-13. Epub 2006 Sep 19. Review.
PMID: 16983483 [PubMed - indexed for MEDLINE]

31: Horowski R.
A history of dopamine agonists. From the physiology and pharmacology of dopamine
to therapies for prolactinomas and Parkinson's disease - a subjective view.
J Neural Transm. 2007 Jan;114(1):127-34. Epub 2006 Aug 10. Review. No abstract
available.
PMID: 16897593 [PubMed - indexed for MEDLINE]

32: Janhunen S, Ahtee L.
Differential nicotinic regulation of the nigrostriatal and mesolimbic
dopaminergic pathways: implications for drug development.
Neurosci Biobehav Rev. 2007;31(3):287-314. Epub 2006 Dec 4. Review.
PMID: 17141870 [PubMed - indexed for MEDLINE]

33: Thobois S, Broussolle E.
[Initial management of Parkinson disease]
Presse Med. 2007 Jan;36(1 Pt 2):86-91. Epub 2006 Dec 11. Review. French.
PMID: 17296476 [PubMed - indexed for MEDLINE]

34: Lévesque D, Rouillard C.
Nur77 and retinoid X receptors: crucial factors in dopamine-related
neuroadaptation.
Trends Neurosci. 2007 Jan;30(1):22-30. Epub 2006 Nov 28. Review.
PMID: 17134767 [PubMed - indexed for MEDLINE]

35: Ludin HP, Surber Ch.
[Prevention and treatment of fluctuations in patients with Parkinson's disease]
Schweiz Rundsch Med Prax. 2006 Dec 20;95(51-52):2013-8. Review. German.
PMID: 17294589 [PubMed - indexed for MEDLINE]

36: Rao SS, Hofmann LA, Shakil A.
Parkinson's disease: diagnosis and treatment.
Am Fam Physician. 2006 Dec 15;74(12):2046-54. Review.
PMID: 17186710 [PubMed - indexed for MEDLINE]

37: Lippa CF, Emre M.
Characterizing clinical phenotypes: the Lewys in their life or the life of their
Lewys?
Neurology. 2006 Dec 12;67(11):1910-1. Review. No abstract available.
PMID: 17159092 [PubMed - indexed for MEDLINE]

38: Ferreri F, Agbokou C, Gauthier S.
Recognition and management of neuropsychiatric complications in Parkinson's
disease.
CMAJ. 2006 Dec 5;175(12):1545-52. Review.
PMID: 17146092 [PubMed - indexed for MEDLINE]

39: [No authors listed]
Rasagiline (Azilect) for Parkinson's disease.
Med Lett Drugs Ther. 2006 Dec 4;48(1249/1250):97-9. Review. No abstract
available.
PMID: 17149358 [PubMed - indexed for MEDLINE]

40: Guay DR.
Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for
Parkinson's disease.
Am J Geriatr Pharmacother. 2006 Dec;4(4):330-46. Review.
PMID: 17296539 [PubMed - indexed for MEDLINE]

41: Dezawa M.
Insights into autotransplantation: the unexpected discovery of specific induction
systems in bone marrow stromal cells.
Cell Mol Life Sci. 2006 Dec;63(23):2764-72. Review.
PMID: 17109065 [PubMed - indexed for MEDLINE]

42: Pellecchia MT, Pivonello R, Colao A, Barone P.
Growth hormone stimulation tests in the differential diagnosis of Parkinson's
disease.
Clin Med Res. 2006 Dec;4(4):322-5. Review.
PMID: 17210980 [PubMed - indexed for MEDLINE]

43: Youdim MB.
The path from anti Parkinson drug selegiline and rasagiline to multifunctional
neuroprotective anti Alzheimer drugs ladostigil and m30.
Curr Alzheimer Res. 2006 Dec;3(5):541-50. Review.
PMID: 17168653 [PubMed - indexed for MEDLINE]

44: Tesseur I, Wyss-Coray T.
A role for TGF-beta signaling in neurodegeneration: evidence from genetically
engineered models.
Curr Alzheimer Res. 2006 Dec;3(5):505-13. Review.
PMID: 17168649 [PubMed - indexed for MEDLINE]

45: Bevan MD, Atherton JF, Baufreton J.
Cellular principles underlying normal and pathological activity in the
subthalamic nucleus.
Curr Opin Neurobiol. 2006 Dec;16(6):621-8. Epub 2006 Nov 3. Review.
PMID: 17084618 [PubMed - indexed for MEDLINE]

46: Rivlin-Etzion M, Marmor O, Heimer G, Raz A, Nini A, Bergman H.
Basal ganglia oscillations and pathophysiology of movement disorders.
Curr Opin Neurobiol. 2006 Dec;16(6):629-37. Epub 2006 Nov 3. Review.
PMID: 17084615 [PubMed - indexed for MEDLINE]

47: Coulthard E, Singh-Curry V, Husain M.
Treatment of attention deficits in neurological disorders.
Curr Opin Neurol. 2006 Dec;19(6):613-8. Review.
PMID: 17102702 [PubMed - indexed for MEDLINE]

48: Chamberlain SR, Müller U, Robbins TW, Sahakian BJ.
Neuropharmacological modulation of cognition.
Curr Opin Neurol. 2006 Dec;19(6):607-12. Review.
PMID: 17102701 [PubMed - indexed for MEDLINE]

49: Burn DJ.
Cortical Lewy body disease and Parkinson's disease dementia.
Curr Opin Neurol. 2006 Dec;19(6):572-9. Review.
PMID: 17102696 [PubMed - indexed for MEDLINE]

50: Giacobbe P, Kennedy SH.
Deep brain stimulation for treatment-resistant depression: a psychiatric
perspective.
Curr Psychiatry Rep. 2006 Dec;8(6):437-44. Review.
PMID: 17094923 [PubMed - indexed for MEDLINE]

51: Zesiewicz TA, Sullivan KL, Hauser RA.
Nonmotor symptoms of Parkinson's disease.
Expert Rev Neurother. 2006 Dec;6(12):1811-22. Review.
PMID: 17181428 [PubMed - indexed for MEDLINE]

52: Witt SN, Flower TR.
alpha-Synuclein, oxidative stress and apoptosis from the perspective of a yeast
model of Parkinson's disease.
FEMS Yeast Res. 2006 Dec;6(8):1107-16. Review.
PMID: 17156009 [PubMed - indexed for MEDLINE]

53: Sohrabji F, Lewis DK.
Estrogen-BDNF interactions: implications for neurodegenerative diseases.
Front Neuroendocrinol. 2006 Dec;27(4):404-14. Epub 2006 Oct 27. Review.
PMID: 17069877 [PubMed - indexed for MEDLINE]

54: Pascual A, Modolo J, Beuter A.
Is a computational model useful to understand the effect of deep brain
stimulation in Parkinson's disease?
J Integr Neurosci. 2006 Dec;5(4):541-59. Review.
PMID: 17245822 [PubMed - indexed for MEDLINE]

55: Tolosa E, Compta Y.
Dystonia in Parkinson's disease.
J Neurol. 2006 Dec;253 Suppl 7:VII7-13. Review.
PMID: 17131231 [PubMed - indexed for MEDLINE]

56: Levy R, Czernecki V.
Apathy and the basal ganglia.
J Neurol. 2006 Dec;253 Suppl 7:VII54-61. Review.
PMID: 17131230 [PubMed - indexed for MEDLINE]

57: Yoshii F, Takahashi H, Kumazawa R, Kobori S.
Parkinson's disease and fatigue.
J Neurol. 2006 Dec;253 Suppl 7:VII48-53. Review.
PMID: 17131229 [PubMed - indexed for MEDLINE]

58: Hirayama M.
Sweating dysfunctions in Parkinson's disease.
J Neurol. 2006 Dec;253 Suppl 7:VII42-47. Review.
PMID: 17131228 [PubMed - indexed for MEDLINE]

59: Kashihara K.
Weight loss in Parkinson's disease.
J Neurol. 2006 Dec;253 Suppl 7:VII38-41. Review.
PMID: 17131227 [PubMed - indexed for MEDLINE]

60: Tan EK.
Restless legs syndrome and Parkinson's disease: is there an etiologic link?
J Neurol. 2006 Dec;253 Suppl 7:VII33-37. Review.
PMID: 17131226 [PubMed - indexed for MEDLINE]

61: Okuma Y.
Freezing of gait in Parkinson's disease.
J Neurol. 2006 Dec;253 Suppl 7:VII27-32. Review.
PMID: 17131225 [PubMed - indexed for MEDLINE]

62: Fujimoto K.
Dropped head in Parkinson's disease.
J Neurol. 2006 Dec;253 Suppl 7:VII21-26. Review.
PMID: 17131224 [PubMed - indexed for MEDLINE]

63: Poewe W.
The natural history of Parkinson's disease.
J Neurol. 2006 Dec;253 Suppl 7:VII2-6. Review.
PMID: 17131223 [PubMed - indexed for MEDLINE]

64: Yokochi F.
Lateral flexion in Parkinson's disease and Pisa syndrome.
J Neurol. 2006 Dec;253 Suppl 7:VII17-20. Review.
PMID: 17131222 [PubMed - indexed for MEDLINE]

65: Melamed E, Djaldetti R.
Camptocormia in Parkinson's disease.
J Neurol. 2006 Dec;253 Suppl 7:VII14-16. Review.
PMID: 17131221 [PubMed - indexed for MEDLINE]

66: Martin LJ.
Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.
J Neuropathol Exp Neurol. 2006 Dec;65(12):1103-10. Review.
PMID: 17146283 [PubMed - indexed for MEDLINE]

67: Jensen JB, Parmar M.
Strengths and limitations of the neurosphere culture system.
Mol Neurobiol. 2006 Dec;34(3):153-61. Review.
PMID: 17308349 [PubMed - indexed for MEDLINE]

68: Braak H, Bohl JR, Müller CM, Rüb U, de Vos RA, Del Tredici K.
Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology
associated with sporadic Parkinson's disease reconsidered.
Mov Disord. 2006 Dec;21(12):2042-51. Review.
PMID: 17078043 [PubMed - indexed for MEDLINE]

69: Okubadejo NU, Bower JH, Rocca WA, Maraganore DM.
Parkinson's disease in Africa: A systematic review of epidemiologic and genetic
studies.
Mov Disord. 2006 Dec;21(12):2150-6. Review.
PMID: 17044056 [PubMed - indexed for MEDLINE]

70: Piccini P, Brooks DJ.
New developments of brain imaging for Parkinson's disease and related disorders.
Mov Disord. 2006 Dec;21(12):2035-41. Review.
PMID: 16874751 [PubMed - indexed for MEDLINE]

71: Maragakis NJ, Rothstein JD.
Mechanisms of Disease: astrocytes in neurodegenerative disease.
Nat Clin Pract Neurol. 2006 Dec;2(12):679-89. Review.
PMID: 17117171 [PubMed - indexed for MEDLINE]

72: Wierink CD, Bots-van 't Spijker PC, de Baat C.
[Specialties in dentistry. Salivary flow and swallowing in Parkinson's disease]
Ned Tijdschr Tandheelkd. 2006 Dec;113(12):502-5. Review. Dutch.
PMID: 17193986 [PubMed - indexed for MEDLINE]

73: Wenzel S, Mollenhauer B, Trenkwalder C.
[Diagnosis and clinical therapy for Parkinson's disease]
Nervenarzt. 2006 Dec;77(12):1439-43. Review. German.
PMID: 17093957 [PubMed - indexed for MEDLINE]

74: Feng J.
Microtubule: a common target for parkin and Parkinson's disease toxins.
Neuroscientist. 2006 Dec;12(6):469-76. Review.
PMID: 17079513 [PubMed - indexed for MEDLINE]

75: Segura-Aguilar J, Kostrzewa RM.
Neurotoxins and neurotoxicity mechanisms. An overview.
Neurotox Res. 2006 Dec;10(3-4):263-87. Review.
PMID: 17197375 [PubMed - indexed for MEDLINE]

76: Youdim MB, Amit T, Bar-Am O, Weinreb O, Yogev-Falach M.
Implications of co-morbidity for etiology and treatment of neurodegenerative
diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil.
Neurotox Res. 2006 Dec;10(3-4):181-92. Review.
PMID: 17197368 [PubMed - indexed for MEDLINE]

77: Mehler-Wex C, Riederer P, Gerlach M.
Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for
the pathophysiology of Parkinson's disease, schizophrenia and attention deficit
hyperactivity disorder.
Neurotox Res. 2006 Dec;10(3-4):167-79. Review.
PMID: 17197367 [PubMed - indexed for MEDLINE]

78: Dinis-Oliveira RJ, Remião F, Carmo H, Duarte JA, Navarro AS, Bastos ML,
Carvalho F.
Paraquat exposure as an etiological factor of Parkinson's disease.
Neurotoxicology. 2006 Dec;27(6):1110-22. Epub 2006 Jul 3. Review.
PMID: 16815551 [PubMed - indexed for MEDLINE]

79: Kavya R, Saluja R, Singh S, Dikshit M.
Nitric oxide synthase regulation and diversity: implications in Parkinson's
disease.
Nitric Oxide. 2006 Dec;15(4):280-94. Epub 2006 Jul 18. Review.
PMID: 16934505 [PubMed - indexed for MEDLINE]

80: Murayama S, Saito Y.
[Brain bank]
No To Shinkei. 2006 Dec;58(12):1075-84. Review. Japanese. No abstract available.
PMID: 17193958 [PubMed - indexed for MEDLINE]

81: Tops M.
Are the insular cortex and cortisol implicated in Parkinsonian features?
Parkinsonism Relat Disord. 2006 Dec;12(8):467-71. Epub 2006 Jun 21. Review.
PMID: 16793317 [PubMed - indexed for MEDLINE]

82: Osthus R, Benos D.
Making the case for NIH funding: how cures are built on decades of research.
Physiologist. 2006 Dec;49(6):313, 319-21. Review. No abstract available.
PMID: 17175749 [PubMed - indexed for MEDLINE]

83: Venneti S, Lopresti BJ, Wiley CA.
The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia:
from pathology to imaging.
Prog Neurobiol. 2006 Dec;80(6):308-22. Epub 2006 Dec 6. Review.
PMID: 17156911 [PubMed - indexed for MEDLINE]

84: Inzitari D, Poggesi A.
[Neurology: the near future]
Recenti Prog Med. 2006 Dec;97(12):670-8. Review. Italian.
PMID: 17252725 [PubMed - indexed for MEDLINE]

85: Boita F, Couderc LJ, Crestani B, de Wazieres B, Devillier P, Ferron C, Franco
A, Guenard H, Hayot M, Housset B, Jeandel C, Kuentz Rousseau M, Orlando JP,
Orvoen-Frija E, Parent B, Partouche H, Piette F, Pinganaud G, Pison C, Puisieux
F, Boucot I, Ruault G; Intergroupe Pneumo Gériatrie SPLF-SFGG.
[Evaluation of pulmonary function in the elderly. Intergroupe Pneumo Gériatrie
SPLF-SFGG]
Rev Mal Respir. 2006 Dec;23(6):619-28. Review. French.
PMID: 17202967 [PubMed - indexed for MEDLINE]

86: Schurr E, Alcaïs A, de Léséleuc L, Abel L.
Genetic predisposition to leprosy: A major gene reveals novel pathways of
immunity to Mycobacterium leprae.
Semin Immunol. 2006 Dec;18(6):404-10. Epub 2006 Sep 14. Review.
PMID: 16973374 [PubMed - indexed for MEDLINE]

87: Adam-Vizi V, Chinopoulos C.
Bioenergetics and the formation of mitochondrial reactive oxygen species.
Trends Pharmacol Sci. 2006 Dec;27(12):639-45. Epub 2006 Oct 23. Review.
PMID: 17056127 [PubMed - indexed for MEDLINE]

88: Simonato M, Tongiorgi E, Kokaia M.
Angels and demons: neurotrophic factors and epilepsy.
Trends Pharmacol Sci. 2006 Dec;27(12):631-8. Epub 2006 Oct 19. Review.
PMID: 17055067 [PubMed - indexed for MEDLINE]

89: Zheng G, Dwoskin LP, Crooks PA.
Vesicular monoamine transporter 2: role as a novel target for drug development.
AAPS J. 2006 Nov 10;8(4):E682-92. Review.
PMID: 17233532 [PubMed - indexed for MEDLINE]

90: Croisier E, Graeber MB.
Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging
concept of primary gliodegeneration.
Acta Neuropathol. 2006 Nov;112(5):517-30. Epub 2006 Aug 1. Review.
PMID: 16896905 [PubMed - indexed for MEDLINE]

91: Tan EK.
Identification of a common genetic risk variant (LRRK2 Gly2385Arg) in Parkinson's
disease.
Ann Acad Med Singapore. 2006 Nov;35(11):840-2. Review.
PMID: 17160203 [PubMed - indexed for MEDLINE]

92: Ragonese P, D'Amelio M, Savettieri G.
Implications for estrogens in Parkinson's disease: an epidemiological approach.
Ann N Y Acad Sci. 2006 Nov;1089:373-82. Review.
PMID: 17261781 [PubMed - indexed for MEDLINE]

93: Favier A.
[Oxidative stress in human diseases]
Ann Pharm Fr. 2006 Nov;64(6):390-6. Review. French.
PMID: 17119468 [PubMed - indexed for MEDLINE]

94: Strous RD, Shoenfeld Y.
To smell the immune system: olfaction, autoimmunity and brain involvement.
Autoimmun Rev. 2006 Nov;6(1):54-60. Epub 2006 Aug 1. Review.
PMID: 17110318 [PubMed - indexed for MEDLINE]

95: Gros-Louis F, Gaspar C, Rouleau GA.
Genetics of familial and sporadic amyotrophic lateral sclerosis.
Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):956-72. Epub 2006 Feb 10. Review.
PMID: 16503123 [PubMed - indexed for MEDLINE]

96: Lin T, Islam O, Heese K.
ABC transporters, neural stem cells and neurogenesis--a different perspective.
Cell Res. 2006 Nov;16(11):857-71. Review.
PMID: 17088897 [PubMed - indexed for MEDLINE]

97: Gilman S.
Parkinsonian syndromes.
Clin Geriatr Med. 2006 Nov;22(4):827-42, vi. Review.
PMID: 17000338 [PubMed - indexed for MEDLINE]

98: Espay AJ, Mandybur GT, Revilla FJ.
Surgical treatment of movement disorders.
Clin Geriatr Med. 2006 Nov;22(4):813-25, vi. Review.
PMID: 17000337 [PubMed - indexed for MEDLINE]

99: Bohnen NI, Cham R.
Postural control, gait, and dopamine functions in parkinsonian movement
disorders.
Clin Geriatr Med. 2006 Nov;22(4):797-812, vi. Review.
PMID: 17000336 [PubMed - indexed for MEDLINE]

100: Barbas NR.
Cognitive, affective, and psychiatric features of Parkinson's disease.
Clin Geriatr Med. 2006 Nov;22(4):773-96, v-vi. Review.
PMID: 17000335 [PubMed - indexed for MEDLINE]

101: Goudreau JL.
Medical management of advanced Parkinson's disease.
Clin Geriatr Med. 2006 Nov;22(4):753-72, v. Review.
PMID: 17000334 [PubMed - indexed for MEDLINE]

102: Albin RL.
Parkinson's disease: background, diagnosis, and initial management.
Clin Geriatr Med. 2006 Nov;22(4):735-51, v. Review.
PMID: 17000333 [PubMed - indexed for MEDLINE]

103: Ebadi M, Brown-Borg H, Ren J, Sharma S, Shavali S, El ReFaey H, Carlson EC.
Therapeutic efficacy of selegiline in neurodegenerative disorders and
neurological diseases.
Curr Drug Targets. 2006 Nov;7(11):1513-29. Review.
PMID: 17100591 [PubMed - indexed for MEDLINE]

104: Kirshner HS, Lavin PJ.
Posterior cortical atrophy: a brief review.
Curr Neurol Neurosci Rep. 2006 Nov;6(6):477-80. Review.
PMID: 17074282 [PubMed - indexed for MEDLINE]

105: Machado JC, Caramelli P.
Treatment of dementia: anything new?
Curr Opin Psychiatry. 2006 Nov;19(6):575-80. Review.
PMID: 17012934 [PubMed - indexed for MEDLINE]

106: Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P,
Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C; European Federation of
Neurological Societies; Movement Disorder Society-European Section.
Review of the therapeutic management of Parkinson's disease. Report of a joint
task force of the European Federation of Neurological Societies (EFNS) and the
Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated)
Parkinson's disease.
Eur J Neurol. 2006 Nov;13(11):1186-202. Review.
PMID: 17038032 [PubMed - indexed for MEDLINE]

107: Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P,
Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C; European Federation of
Neurological Societies; Movement Disorder Society-European Section.
Review of the therapeutic management of Parkinson's disease. Report of a joint
task force of the European Federation of Neurological Societies and the Movement
Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's
disease.
Eur J Neurol. 2006 Nov;13(11):1170-85. Review.
PMID: 17038031 [PubMed - indexed for MEDLINE]

108: Mena MA, de Yébenes JG.
Drug-induced parkinsonism.
Expert Opin Drug Saf. 2006 Nov;5(6):759-71. Review.
PMID: 17044803 [PubMed - indexed for MEDLINE]

109: Leegwater-Kim J, Waters C.
Tolcapone in the management of Parkinson's disease.
Expert Opin Pharmacother. 2006 Nov;7(16):2263-70. Review.
PMID: 17059382 [PubMed - indexed for MEDLINE]

110: Moro E, Lang AE.
Criteria for deep-brain stimulation in Parkinson's disease: review and analysis.
Expert Rev Neurother. 2006 Nov;6(11):1695-705. Review.
PMID: 17144783 [PubMed - indexed for MEDLINE]

111: Pérez-Navarro E, Canals JM, Ginés S, Alberch J.
Cellular and molecular mechanisms involved in the selective vulnerability of
striatal projection neurons in Huntington's disease.
Histol Histopathol. 2006 Nov;21(11):1217-32. Review.
PMID: 16874665 [PubMed - indexed for MEDLINE]

112: Yokel RA.
Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected
to contribute to metal-induced neurodegeneration.
J Alzheimers Dis. 2006 Nov;10(2-3):223-53. Review.
PMID: 17119290 [PubMed - indexed for MEDLINE]

113: Abeliovich A, Flint Beal M.
Parkinsonism genes: culprits and clues.
J Neurochem. 2006 Nov;99(4):1062-72. Epub 2006 Jul 6. Review.
PMID: 16836655 [PubMed - indexed for MEDLINE]

114: Calabresi P, Picconi B, Parnetti L, Di Filippo M.
A convergent model for cognitive dysfunctions in Parkinson's disease: the
critical dopamine-acetylcholine synaptic balance.
Lancet Neurol. 2006 Nov;5(11):974-83. Review.
PMID: 17052664 [PubMed - indexed for MEDLINE]

115: Olanow CW, McNaught KS.
Ubiquitin-proteasome system and Parkinson's disease.
Mov Disord. 2006 Nov;21(11):1806-23. Review.
PMID: 16972273 [PubMed - indexed for MEDLINE]

116: Bachmann CG, Trenkwalder C.
Body weight in patients with Parkinson's disease.
Mov Disord. 2006 Nov;21(11):1824-30. Review.
PMID: 16958133 [PubMed - indexed for MEDLINE]

117: Colosimo C, Fabbrini G, Berardelli A.
Drug Insight: new drugs in development for Parkinson's disease.
Nat Clin Pract Neurol. 2006 Nov;2(11):600-10. Review.
PMID: 17057747 [PubMed - indexed for MEDLINE]

118: Lindsey KP, Gatley SJ.
Applications of clinical dopamine imaging.
Neuroimaging Clin N Am. 2006 Nov;16(4):553-73, vii-viii. Review.
PMID: 17148019 [PubMed - indexed for MEDLINE]

119: Nowak P, Szczerbak G, Dabrowska J, Bortel A, Biedka I, Kostrzewa RM.
[Molecular mechanisms of levodopa action in animal models of Parkinson's disease]
Neurol Neurochir Pol. 2006 Nov-Dec;40(6):517-25. Review. Polish.
PMID: 17199178 [PubMed - indexed for MEDLINE]

120: Richtand NM.
Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated
inhibitory function.
Neuropsychopharmacology. 2006 Nov;31(11):2368-75. Epub 2006 Jul 19. Review.
PMID: 16855531 [PubMed - indexed for MEDLINE]

121: Asanuma K.
[Study of movement disorder with network analysis]
No To Shinkei. 2006 Nov;58(11):977-85. Review. Japanese. No abstract available.
PMID: 17134005 [PubMed - indexed for MEDLINE]

122: Samaras D, Carmona G, Vischer U, Perrenoud JJ.
[Postprandial hypotension: an unclear clinical entity]
Rev Med Suisse. 2006 Nov 1;2(85):2456-8, 2460-1. Review. French.
PMID: 17120714 [PubMed - indexed for MEDLINE]

123: Chastan N, Hartmann A.
[Medical management of patients with atypical degenerative parkinsonian
syndromes]
Rev Neurol (Paris). 2006 Nov;162(11):1147-58. Review. French.
PMID: 17086154 [PubMed - indexed for MEDLINE]

124: Lorincz MT.
Clinical implications of Parkinson's disease genetics.
Semin Neurol. 2006 Nov;26(5):492-8. Review.
PMID: 17048150 [PubMed - indexed for MEDLINE]

125: Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG.
The science and practice of LSVT/LOUD: neural plasticity-principled approach to
treating individuals with Parkinson disease and other neurological disorders.
Semin Speech Lang. 2006 Nov;27(4):283-99. Review.
PMID: 17117354 [PubMed - indexed for MEDLINE]

126: Solomon NP.
What is orofacial fatigue and how does it affect function for swallowing and
speech?
Semin Speech Lang. 2006 Nov;27(4):268-82. Review.
PMID: 17117353 [PubMed - indexed for MEDLINE]

127: Sapienza CM, Wheeler K.
Respiratory muscle strength training: functional outcomes versus plasticity.
Semin Speech Lang. 2006 Nov;27(4):236-44. Review.
PMID: 17117350 [PubMed - indexed for MEDLINE]

128: Logemann JA.
Levels of evidence supporting dysphagia interventions: where are we going?
Semin Speech Lang. 2006 Nov;27(4):219-26. Review.
PMID: 17117348 [PubMed - indexed for MEDLINE]

129: Wood-Kaczmar A, Gandhi S, Wood NW.
Understanding the molecular causes of Parkinson's disease.
Trends Mol Med. 2006 Nov;12(11):521-8. Epub 2006 Oct 5. Review.
PMID: 17027339 [PubMed - indexed for MEDLINE]

130: Burbach JP, Smidt MP.
Molecular programming of stem cells into mesodiencephalic dopaminergic neurons.
Trends Neurosci. 2006 Nov;29(11):601-3. Epub 2006 Oct 9. Review.
PMID: 17030431 [PubMed - indexed for MEDLINE]

131: Schwarzschild MA, Agnati L, Fuxe K, Chen JF, Morelli M.
Targeting adenosine A2A receptors in Parkinson's disease.
Trends Neurosci. 2006 Nov;29(11):647-54. Epub 2006 Oct 9. Review.
PMID: 17030429 [PubMed - indexed for MEDLINE]

132: Korczyn AD.
Management of sleep problems in Parkinson's disease.
J Neurol Sci. 2006 Oct 25;248(1-2):163-6. Epub 2006 Oct 10. Review.
PMID: 17045298 [PubMed - indexed for MEDLINE]

133: Korczyn AD, Reichmann H.
Dementia with Lewy bodies.
J Neurol Sci. 2006 Oct 25;248(1-2):3-8. Epub 2006 Oct 10. Review.
PMID: 17034818 [PubMed - indexed for MEDLINE]

134: Braak H, Rüb U, Del Tredici K.
Cognitive decline correlates with neuropathological stage in Parkinson's disease.
J Neurol Sci. 2006 Oct 25;248(1-2):255-8. Epub 2006 Jun 30. Review.
PMID: 16814807 [PubMed - indexed for MEDLINE]

135: Kalda A, Yu L, Oztas E, Chen JF.
Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in
animal models of Parkinson's disease.
J Neurol Sci. 2006 Oct 25;248(1-2):9-15. Epub 2006 Jun 27. Review.
PMID: 16806272 [PubMed - indexed for MEDLINE]

136: Leroi I, Collins D, Marsh L.
Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's
disease: a review.
J Neurol Sci. 2006 Oct 25;248(1-2):104-14. Epub 2006 Jun 27. Review.
PMID: 16806271 [PubMed - indexed for MEDLINE]

137: Bloem BR, Grimbergen YA, van Dijk JG, Munneke M.
The "posture second" strategy: a review of wrong priorities in Parkinson's
disease.
J Neurol Sci. 2006 Oct 25;248(1-2):196-204. Epub 2006 Jun 27. Review.
PMID: 16806270 [PubMed - indexed for MEDLINE]

138: Onofrj M, Bonanni L, Albani G, Mauro A, Bulla D, Thomas A.
Visual hallucinations in Parkinson's disease: clues to separate origins.
J Neurol Sci. 2006 Oct 25;248(1-2):143-50. Epub 2006 Jun 23. Review.
PMID: 16806269 [PubMed - indexed for MEDLINE]

139: Schrag A.
Quality of life and depression in Parkinson's disease.
J Neurol Sci. 2006 Oct 25;248(1-2):151-7. Epub 2006 Jun 21. Review.
PMID: 16797028 [PubMed - indexed for MEDLINE]

140: Helmich RC, Siebner HR, Bakker M, Münchau A, Bloem BR.
Repetitive transcranial magnetic stimulation to improve mood and motor function
in Parkinson's disease.
J Neurol Sci. 2006 Oct 25;248(1-2):84-96. Epub 2006 Jun 21. Review.
PMID: 16793065 [PubMed - indexed for MEDLINE]

141: Reichmann H.
Budipine in Parkinson's tremor.
J Neurol Sci. 2006 Oct 25;248(1-2):53-5. Epub 2006 Jun 19. Review.
PMID: 16784759 [PubMed - indexed for MEDLINE]

142: Giladi N, Hausdorff JM.
The role of mental function in the pathogenesis of freezing of gait in
Parkinson's disease.
J Neurol Sci. 2006 Oct 25;248(1-2):173-6. Epub 2006 Jun 14. Review.
PMID: 16780886 [PubMed - indexed for MEDLINE]

143: Rektor I, Rektorová I, Kubová D.
Vascular parkinsonism--an update.
J Neurol Sci. 2006 Oct 25;248(1-2):185-91. Review.
PMID: 16765989 [PubMed - indexed for MEDLINE]

144: Winn P.
How best to consider the structure and function of the pedunculopontine tegmental
nucleus: evidence from animal studies.
J Neurol Sci. 2006 Oct 25;248(1-2):234-50. Epub 2006 Jun 9. Review.
PMID: 16765383 [PubMed - indexed for MEDLINE]

145: Azulay JP, Mesure S, Blin O.
Influence of visual cues on gait in Parkinson's disease: contribution to
attention or sensory dependence?
J Neurol Sci. 2006 Oct 25;248(1-2):192-5. Epub 2006 Jun 9. Review.
PMID: 16765379 [PubMed - indexed for MEDLINE]

146: Hilker R, Burghaus L, Razai N, Jacobs AH, Szelies B, Heiss WD.
Functional brain imaging in combined motor and sleep disorders.
J Neurol Sci. 2006 Oct 25;248(1-2):223-6. Epub 2006 Jun 5. Review.
PMID: 16753181 [PubMed - indexed for MEDLINE]

147: Bredesen DE, Rao RV, Mehlen P.
Cell death in the nervous system.
Nature. 2006 Oct 19;443(7113):796-802. Review.
PMID: 17051206 [PubMed - indexed for MEDLINE]

148: Rubinsztein DC.
The roles of intracellular protein-degradation pathways in neurodegeneration.
Nature. 2006 Oct 19;443(7113):780-6. Review.
PMID: 17051204 [PubMed - indexed for MEDLINE]

149: Lansbury PT, Lashuel HA.
A century-old debate on protein aggregation and neurodegeneration enters the
clinic.
Nature. 2006 Oct 19;443(7113):774-9. Review.
PMID: 17051203 [PubMed - indexed for MEDLINE]

150: Winograd-Gurvich C, Fitzgerald PB, Georgiou-Karistianis N, Bradshaw JL,
White OB.
Negative symptoms: A review of schizophrenia, melancholic depression and
Parkinson's disease.
Brain Res Bull. 2006 Oct 16;70(4-6):312-21. Epub 2006 Jul 5. Review.
PMID: 17027767 [PubMed - indexed for MEDLINE]

151: Schiff PL.
Ergot and its alkaloids.
Am J Pharm Educ. 2006 Oct 15;70(5):98. Review.
PMID: 17149427 [PubMed - indexed for MEDLINE]

152: Pittman AM, Fung HC, de Silva R.
Untangling the tau gene association with neurodegenerative disorders.
Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R188-95. Review.
PMID: 16987883 [PubMed - indexed for MEDLINE]

153: Zecca L, Zucca FA, Albertini A, Rizzio E, Fariello RG.
A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease.
Neurology. 2006 Oct 10;67(7 Suppl 2):S8-11. Review.
PMID: 17030740 [PubMed - indexed for MEDLINE]

154: Bonuccelli U, Del Dotto P.
New pharmacologic horizons in the treatment of Parkinson disease.
Neurology. 2006 Oct 10;67(7 Suppl 2):S30-8. Review.
PMID: 17030738 [PubMed - indexed for MEDLINE]

155: Caccia C, Maj R, Calabresi M, Maestroni S, Faravelli L, Curatolo L, Salvati
P, Fariello RG.
Safinamide: from molecular targets to a new anti-Parkinson drug.
Neurology. 2006 Oct 10;67(7 Suppl 2):S18-23. Review.
PMID: 17030736 [PubMed - indexed for MEDLINE]

156: Wichmann T, Delong MR.
Deep brain stimulation for neurologic and neuropsychiatric disorders.
Neuron. 2006 Oct 5;52(1):197-204. Review.
PMID: 17015236 [PubMed - indexed for MEDLINE]

157: Uhlhaas PJ, Singer W.
Neural synchrony in brain disorders: relevance for cognitive dysfunctions and
pathophysiology.
Neuron. 2006 Oct 5;52(1):155-68. Review.
PMID: 17015233 [PubMed - indexed for MEDLINE]

158: Lee VM, Trojanowski JQ.
Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new
targets for drug discovery.
Neuron. 2006 Oct 5;52(1):33-8. Review.
PMID: 17015225 [PubMed - indexed for MEDLINE]

159: Johannsen P.
[Medical treatment of Alzheimer's disease]
Ugeskr Laeger. 2006 Oct 2;168(40):3424-9. Review. Danish.
PMID: 17032609 [PubMed - indexed for MEDLINE]

160: Galvin JE.
Cognitive change in Parkinson disease.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):302-10. Review.
PMID: 17132978 [PubMed - indexed for MEDLINE]

161: Duff K.
Normal and abnormal tau neurobiology.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):202-5. Review. No abstract
available.
PMID: 17132962 [PubMed - indexed for MEDLINE]

162: Carter GT, Han JJ, Mayadev A, Weiss MD.
Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.
Am J Hosp Palliat Care. 2006 Oct-Nov;23(5):412-6. Review.
PMID: 17060310 [PubMed - indexed for MEDLINE]

163: Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A.
Genetics of Parkinson's disease and parkinsonism.
Ann Neurol. 2006 Oct;60(4):389-98. Review.
PMID: 17068789 [PubMed - indexed for MEDLINE]

164: Biskup S, Moore DJ.
Detrimental deletions: mitochondria, aging and Parkinson's disease.
Bioessays. 2006 Oct;28(10):963-7. Review.
PMID: 16998822 [PubMed - indexed for MEDLINE]

165: Coppedè F, Mancuso M, Siciliano G, Migliore L, Murri L.
Genes and the environment in neurodegeneration.
Biosci Rep. 2006 Oct;26(5):341-67. Review.
PMID: 17029001 [PubMed - indexed for MEDLINE]

166: Skrabana R, Sevcik J, Novak M.
Intrinsically disordered proteins in the neurodegenerative processes: formation
of tau protein paired helical filaments and their analysis.
Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1085-97. Epub 2006 Jun 16. Review.
PMID: 16779670 [PubMed - indexed for MEDLINE]

167: Sidransky E.
Heterozygosity for a Mendelian disorder as a risk factor for complex disease.
Clin Genet. 2006 Oct;70(4):275-82. Review.
PMID: 16965318 [PubMed - indexed for MEDLINE]

168: Saez ME, Ramirez-Lorca R, Moron FJ, Ruiz A.
The therapeutic potential of the calpain family: new aspects.
Drug Discov Today. 2006 Oct;11(19-20):917-23. Epub 2006 Sep 7. Review.
PMID: 16997142 [PubMed - indexed for MEDLINE]

169: Camins A, Verdaguer E, Folch J, Canudas AM, Pallàs M.
The role of CDK5/P25 formation/inhibition in neurodegeneration.
Drug News Perspect. 2006 Oct;19(8):453-60. Review.
PMID: 17160145 [PubMed - indexed for MEDLINE]

170: Nyholm D.
Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations
and dyskinesias in advanced Parkinson's disease.
Expert Rev Neurother. 2006 Oct;6(10):1403-11. Review.
PMID: 17078781 [PubMed - indexed for MEDLINE]

171: Montoya A, Price BH, Lepage M.
Neural correlates of 'functional' symptoms in neurology.
Funct Neurol. 2006 Oct-Dec;21(4):193-7. Review.
PMID: 17367578 [PubMed - indexed for MEDLINE]

172: Clubb VJ, Clubb SE, Buckley S.
Parkinson's disease patients who fracture their neck of femur: a review of
outcome data.
Injury. 2006 Oct;37(10):929-34. Epub 2006 Feb 17. Review.
PMID: 16483578 [PubMed - indexed for MEDLINE]

173: Chua CE, Tang BL.
alpha-synuclein and Parkinson's disease: the first roadblock.
J Cell Mol Med. 2006 Oct-Dec;10(4):837-46. Review.
PMID: 17125588 [PubMed - indexed for MEDLINE]

174: Cenci MA, Lundblad M.
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
J Neurochem. 2006 Oct;99(2):381-92. Epub 2006 Aug 29. Review.
PMID: 16942598 [PubMed - indexed for MEDLINE]

175: Boland B, Nixon RA.
Neuronal macroautophagy: from development to degeneration.
Mol Aspects Med. 2006 Oct-Dec;27(5-6):503-19. Epub 2006 Sep 26. Review.
PMID: 16999991 [PubMed - indexed for MEDLINE]

176: Ravikumar B, Rubinsztein DC.
Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?
Mol Aspects Med. 2006 Oct-Dec;27(5-6):520-7. Epub 2006 Sep 14. Review.
PMID: 16973207 [PubMed - indexed for MEDLINE]

177: Gatev P, Darbin O, Wichmann T.
Oscillations in the basal ganglia under normal conditions and in movement
disorders.
Mov Disord. 2006 Oct;21(10):1566-77. Review.
PMID: 16830313 [PubMed - indexed for MEDLINE]

178: Meredith GE, Kang UJ.
Behavioral models of Parkinson's disease in rodents: a new look at an old
problem.
Mov Disord. 2006 Oct;21(10):1595-606. Review.
PMID: 16830310 [PubMed - indexed for MEDLINE]

179: Chung V, Liu L, Bian Z, Zhao Z, Leuk Fong W, Kum WF, Gao J, Li M.
Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a
systematic review.
Mov Disord. 2006 Oct;21(10):1709-15. Review.
PMID: 16830309 [PubMed - indexed for MEDLINE]

180: Weiner WJ.
Levodopa--toxic or neuroprotective?
Nat Clin Pract Neurol. 2006 Oct;2(10):518-9. Review. No abstract available.
PMID: 16990820 [PubMed - indexed for MEDLINE]

181: Schapira AH, Bezard E, Brotchie J, Calon F, Collingridge GL, Ferger B,
Hengerer B, Hirsch E, Jenner P, Le Novère N, Obeso JA, Schwarzschild MA,
Spampinato U, Davidai G.
Novel pharmacological targets for the treatment of Parkinson's disease.
Nat Rev Drug Discov. 2006 Oct;5(10):845-54. Review.
PMID: 17016425 [PubMed - indexed for MEDLINE]

182: Fujita M, Wei J, Nakai M, Masliah E, Hashimoto M.
Chaperone and anti-chaperone: two-faced synuclein as stimulator of synaptic
evolution.
Neuropathology. 2006 Oct;26(5):383-92. Review.
PMID: 17080714 [PubMed - indexed for MEDLINE]

183: Chard SE.
Community neurorehabilitation: a synthesis of current evidence and future
research directions.
NeuroRx. 2006 Oct;3(4):525-34. Review.
PMID: 17012066 [PubMed - indexed for MEDLINE]

184: Schmidt WJ, Beninger RJ.
Behavioural sensitization in addiction, schizophrenia, Parkinson's disease and
dyskinesia.
Neurotox Res. 2006 Oct;10(2):161-6. Review.
PMID: 17062377 [PubMed - indexed for MEDLINE]

185: Sellbach AN, Boyle RS, Silburn PA, Mellick GD.
Parkinson's disease and family history.
Parkinsonism Relat Disord. 2006 Oct;12(7):399-409. Epub 2006 Jun 22. Review.
PMID: 16797215 [PubMed - indexed for MEDLINE]

186: Cáceda R, Kinkead B, Nemeroff CB.
Neurotensin: role in psychiatric and neurological diseases.
Peptides. 2006 Oct;27(10):2385-404. Epub 2006 Aug 4. Review.
PMID: 16891042 [PubMed - indexed for MEDLINE]

187: Boules M, Fredrickson P, Richelson E.
Bioactive analogs of neurotensin: focus on CNS effects.
Peptides. 2006 Oct;27(10):2523-33. Epub 2006 Aug 1. Review.
PMID: 16882457 [PubMed - indexed for MEDLINE]

188: Morris ME.
Locomotor training in people with Parkinson disease.
Phys Ther. 2006 Oct;86(10):1426-35. Review.
PMID: 17012646 [PubMed - indexed for MEDLINE]

189: Liu B.
Modulation of microglial pro-inflammatory and neurotoxic activity for the
treatment of Parkinson's disease.
AAPS J. 2006 Sep 29;8(3):E606-21. Review.
PMID: 17025278 [PubMed - indexed for MEDLINE]

190: Goldman SA, Windrem MS.
Cell replacement therapy in neurological disease.
Philos Trans R Soc Lond B Biol Sci. 2006 Sep 29;361(1473):1463-75. Review.
PMID: 16939969 [PubMed - indexed for MEDLINE]

191: Fink AL.
The aggregation and fibrillation of alpha-synuclein.
Acc Chem Res. 2006 Sep;39(9):628-34. Review.
PMID: 16981679 [PubMed - indexed for MEDLINE]

192: Bieschke J, Zhang Q, Bosco DA, Lerner RA, Powers ET, Wentworth P Jr, Kelly
JW.
Small molecule oxidation products trigger disease-associated protein misfolding.
Acc Chem Res. 2006 Sep;39(9):611-9. Review.
PMID: 16981677 [PubMed - indexed for MEDLINE]

193: Tai CH, Kuo CC.
[Electrophysiology of subthalamic nucleus in normal and Parkinson's disease]
Acta Neurol Taiwan. 2006 Sep;15(3):206-16. Review. Chinese. Erratum in: Acta
Neurol Taiwan. 2006 Dec;15(4):7A.
PMID: 16995602 [PubMed - indexed for MEDLINE]

194: Chen S, Le W.
Neuroprotective therapy in Parkinson disease.
Am J Ther. 2006 Sep-Oct;13(5):445-57. Review.
PMID: 16988541 [PubMed - indexed for MEDLINE]

195: Garbayo E, Aymerich MS, Ansorena E, Lanciego JL, Blanco-Prieto MJ.
[Neuroprotective and neurorestorative therapies for the treatment of Parkinson's
disease]
An Sist Sanit Navar. 2006 Sep-Dec;29(3):325-35. Review. Spanish.
PMID: 17224935 [PubMed - indexed for MEDLINE]

196: Tan EK, Jankovic J.
Genetic testing in Parkinson disease: promises and pitfalls.
Arch Neurol. 2006 Sep;63(9):1232-7. Review. No abstract available.
PMID: 16966499 [PubMed - indexed for MEDLINE]

197: Schapira AH.
The importance of LRRK2 mutations in Parkinson disease.
Arch Neurol. 2006 Sep;63(9):1225-8. Review. No abstract available.
PMID: 16966498 [PubMed - indexed for MEDLINE]

198: Tuch BE.
Stem cells--a clinical update.
Aust Fam Physician. 2006 Sep;35(9):719-21. Review.
PMID: 16969445 [PubMed - indexed for MEDLINE]

199: Gasior M, Rogawski MA, Hartman AL.
Neuroprotective and disease-modifying effects of the ketogenic diet.
Behav Pharmacol. 2006 Sep;17(5-6):431-9. Review.
PMID: 16940764 [PubMed - indexed for MEDLINE]

200: Li Q, Zhao D, Bezard E.
Traditional Chinese medicine for Parkinson's disease: a review of Chinese
literature.
Behav Pharmacol. 2006 Sep;17(5-6):403-10. Review.
PMID: 16940761 [PubMed - indexed for MEDLINE]

201: Carta AR, Pinna A, Morelli M.
How reliable is the behavioural evaluation of dyskinesia in animal models of
Parkinson's disease?
Behav Pharmacol. 2006 Sep;17(5-6):393-402. Review.
PMID: 16940760 [PubMed - indexed for MEDLINE]

202: Fleming SM, Chesselet MF.
Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism.
Behav Pharmacol. 2006 Sep;17(5-6):383-91. Review.
PMID: 16940759 [PubMed - indexed for MEDLINE]

203: Pacheco-López G, Engler H, Niemi MB, Schedlowski M.
Expectations and associations that heal: Immunomodulatory placebo effects and its
neurobiology.
Brain Behav Immun. 2006 Sep;20(5):430-46. Epub 2006 Aug 2. Review.
PMID: 16887325 [PubMed - indexed for MEDLINE]

204: Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T.
Transplantation of autologous sympathetic neurons as a potential strategy to
restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals
in Parkinson's disease.
Brain Res Rev. 2006 Sep;52(2):244-56. Epub 2006 Apr 27. Review.
PMID: 16644019 [PubMed - indexed for MEDLINE]

205: Eyal A, Engelender S.
Synphilin isoforms and the search for a cellular model of lewy body formation in
Parkinson's disease.
Cell Cycle. 2006 Sep;5(18):2082-6. Epub 2006 Sep 15. Review.
PMID: 16969096 [PubMed - indexed for MEDLINE]

206: Crizzle AM, Newhouse IJ.
Is physical exercise beneficial for persons with Parkinson's disease?
Clin J Sport Med. 2006 Sep;16(5):422-5. Review.
PMID: 17016120 [PubMed - indexed for MEDLINE]

207: Kolls BJ, Stacy M.
Apomorphine: a rapid rescue agent for the management of motor fluctuations in
advanced Parkinson disease.
Clin Neuropharmacol. 2006 Sep-Oct;29(5):292-301. Review.
PMID: 16960475 [PubMed - indexed for MEDLINE]

208: Garruto RM.
A commentary on neuronal degeneration and cell death in Guam ALS and PD: an
evolutionary process of understanding.
Curr Alzheimer Res. 2006 Sep;3(4):397-401. Review.
PMID: 17017870 [PubMed - indexed for MEDLINE]

209: Springer W, Kahle PJ.
Mechanisms and models of alpha-synuclein-related neurodegeneration.
Curr Neurol Neurosci Rep. 2006 Sep;6(5):432-6. Review.
PMID: 16928354 [PubMed - indexed for MEDLINE]

210: Albers MW, Tabert MH, Devanand DP.
Olfactory dysfunction as a predictor of neurodegenerative disease.
Curr Neurol Neurosci Rep. 2006 Sep;6(5):379-86. Review.
PMID: 16928347 [PubMed - indexed for MEDLINE]

211: Bonifati V.
The pleomorphic pathology of inherited Parkinson's disease: lessons from LRRK2.
Curr Neurol Neurosci Rep. 2006 Sep;6(5):355-7. Review. No abstract available.
PMID: 16928343 [PubMed - indexed for MEDLINE]

212: Ang SL.
Transcriptional control of midbrain dopaminergic neuron development.
Development. 2006 Sep;133(18):3499-506. Epub 2006 Aug 9. Review.
PMID: 16899537 [PubMed - indexed for MEDLINE]

213: Ramassamy C.
Emerging role of polyphenolic compounds in the treatment of neurodegenerative
diseases: a review of their intracellular targets.
Eur J Pharmacol. 2006 Sep 1;545(1):51-64. Epub 2006 Jun 17. Review.
PMID: 16904103 [PubMed - indexed for MEDLINE]

214: Gardoni F, Di Luca M.
New targets for pharmacological intervention in the glutamatergic synapse.
Eur J Pharmacol. 2006 Sep 1;545(1):2-10. Epub 2006 Jun 15. Review.
PMID: 16831414 [PubMed - indexed for MEDLINE]

215: Iacovelli L, Fulceri F, De Blasi A, Nicoletti F, Ruggieri S, Fornai F.
The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative
disorders.
Exp Neurol. 2006 Sep;201(1):24-31. Epub 2006 May 5. Review.
PMID: 16678160 [PubMed - indexed for MEDLINE]

216: Morgan JC, Sethi KD.
Emerging drugs for Parkinson's disease.
Expert Opin Emerg Drugs. 2006 Sep;11(3):403-17. Review.
PMID: 16939381 [PubMed - indexed for MEDLINE]

217: Müller T, Russ H.
Levodopa, motor fluctuations and dyskinesia in Parkinson's disease.
Expert Opin Pharmacother. 2006 Sep;7(13):1715-30. Review.
PMID: 16925499 [PubMed - indexed for MEDLINE]

218: Asanuma M, Miyazaki I.
Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement
of quinone formation.
Expert Rev Neurother. 2006 Sep;6(9):1313-25. Review.
PMID: 17009919 [PubMed - indexed for MEDLINE]

219: Morgan JC, Sethi KD.
Rotigotine for the treatment of Parkinson's disease.
Expert Rev Neurother. 2006 Sep;6(9):1275-82. Review.
PMID: 17009915 [PubMed - indexed for MEDLINE]

220: Hauser RA.
Long-term care of Parkinson's disease. Strategies for managing "wearing off"
symptom re-emergence and dyskinesias.
Geriatrics. 2006 Sep;61(9):14-20. Review.
PMID: 16989543 [PubMed - indexed for MEDLINE]

221: Battista N, Fezza F, Finazzi-Agrò A, Maccarrone M.
The endocannabinoid system in neurodegeneration.
Ital J Biochem. 2006 Sep-Dec;55(3-4):283-9. Review.
PMID: 17274532 [PubMed - indexed for MEDLINE]

222: Lenaz G, Baracca A, Fato R, Genova ML, Solaini G.
Mitochondrial Complex I: structure, function, and implications in
neurodegeneration.
Ital J Biochem. 2006 Sep-Dec;55(3-4):232-53. Review.
PMID: 17274529 [PubMed - indexed for MEDLINE]

223: Mancuso M, Coppede F, Migliore L, Siciliano G, Murri L.
Mitochondrial dysfunction, oxidative stress and neurodegeneration.
J Alzheimers Dis. 2006 Sep;10(1):59-73. Review.
PMID: 16988483 [PubMed - indexed for MEDLINE]

224: Tse W.
Optimizing pharmacotherapy: strategies to manage the wearing-off phenomenon.
J Am Med Dir Assoc. 2006 Sep;7(7 Suppl 2):12-7. Review.
PMID: 17948614 [PubMed - indexed for MEDLINE]

225: Pahwa R.
Understanding Parkinson's disease: an update on current diagnostic and treatment
strategies.
J Am Med Dir Assoc. 2006 Sep;7(7 Suppl 2):4-10. Review.
PMID: 17948613 [PubMed - indexed for MEDLINE]

226: Obata T.
Nitric oxide and MPP+-induced hydroxyl radical generation.
J Neural Transm. 2006 Sep;113(9):1131-44. Epub 2006 Feb 6. Review.
PMID: 16463115 [PubMed - indexed for MEDLINE]

227: Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD.
Blood-brain barrier: structural components and function under physiologic and
pathologic conditions.
J Neuroimmune Pharmacol. 2006 Sep;1(3):223-36. Epub 2006 Jul 6. Review.
PMID: 18040800 [PubMed - indexed for MEDLINE]

228: Suzuki H.
Protein-protein interactions in the mammalian brain.
J Physiol. 2006 Sep 1;575(Pt 2):373-7. Epub 2006 Jul 13. Review.
PMID: 16840513 [PubMed - indexed for MEDLINE]

229: Prakash N, Wurst W.
Genetic networks controlling the development of midbrain dopaminergic neurons.
J Physiol. 2006 Sep 1;575(Pt 2):403-10. Epub 2006 Jul 6. Review.
PMID: 16825303 [PubMed - indexed for MEDLINE]

230: Jacobs FM, Smits SM, Hornman KJ, Burbach JP, Smidt MP.
Strategies to unravel molecular codes essential for the development of
meso-diencephalic dopaminergic neurons.
J Physiol. 2006 Sep 1;575(Pt 2):397-402. Epub 2006 Jun 29. Review.
PMID: 16809365 [PubMed - indexed for MEDLINE]

231: Greene JG.
Gene expression profiles of brain dopamine neurons and relevance to
neuropsychiatric disease.
J Physiol. 2006 Sep 1;575(Pt 2):411-6. Epub 2006 Jun 1. Review.
PMID: 16740610 [PubMed - indexed for MEDLINE]

232: Djaldetti R, Ziv I, Melamed E.
The mystery of motor asymmetry in Parkinson's disease.
Lancet Neurol. 2006 Sep;5(9):796-802. Review.
PMID: 16914408 [PubMed - indexed for MEDLINE]

233: Rolan T.
Sleep and Parkinson's disease.
Mo Med. 2006 Sep-Oct;103(5):529-32. Review.
PMID: 17133758 [PubMed - indexed for MEDLINE]

234: Berg D, Hochstrasser H.
Iron metabolism in Parkinsonian syndromes.
Mov Disord. 2006 Sep;21(9):1299-310. Review.
PMID: 16817199 [PubMed - indexed for MEDLINE]

235: Nithianantharajah J, Hannan AJ.
Enriched environments, experience-dependent plasticity and disorders of the
nervous system.
Nat Rev Neurosci. 2006 Sep;7(9):697-709. Review.
PMID: 16924259 [PubMed - indexed for MEDLINE]

236: Sobstyl M, Zabek M.
[Deep brain stimulation in the treatment of dystonia]
Neurol Neurochir Pol. 2006 Sep-Oct;40(5):413-21. Review. Polish.
PMID: 17103355 [PubMed - indexed for MEDLINE]

237: Linazasoro G, van Blercom N.
[Treatment of Parkinson disease: therapeutic reserve of the dopaminergic agonist]
Neurologia. 2006 Sep;21(7):365-75. Review. Spanish.
PMID: 16977557 [PubMed - indexed for MEDLINE]

238: Lester J, Otero-Siliceo E.
Parkinson's disease and genetics.
Neurologist. 2006 Sep;12(5):240-4. Review.
PMID: 16990735 [PubMed - indexed for MEDLINE]

239: Defebvre L.
Myoclonus and extrapyramidal diseases.
Neurophysiol Clin. 2006 Sep-Dec;36(5-6):319-25. Epub 2006 Dec 13. Review.
PMID: 17336776 [PubMed - indexed for MEDLINE]

240: Fitsanakis VA, Zhang N, Avison MJ, Gore JC, Aschner JL, Aschner M.
The use of magnetic resonance imaging (MRI) in the study of manganese
neurotoxicity.
Neurotoxicology. 2006 Sep;27(5):798-806. Epub 2006 Apr 18. Review.
PMID: 16620989 [PubMed - indexed for MEDLINE]

241: Maruyama T.
[Social cognitive deficits in Parkinson's disease]
No To Shinkei. 2006 Sep;58(9):757-61. Review. Japanese. No abstract available.
PMID: 17052002 [PubMed - indexed for MEDLINE]

242: Kurita A.
[Hallucinations in Parkinson's disease: their clinical picture, pathophysiology
and treatment]
No To Shinkei. 2006 Sep;58(9):747-55. Review. Japanese. No abstract available.
PMID: 17052001 [PubMed - indexed for MEDLINE]

243: Iseki K, Fukuyama H.
[Kinesié paradoxale--paradoxical movement]
No To Shinkei. 2006 Sep;58(9):739-46. Review. Japanese. No abstract available.
PMID: 17052000 [PubMed - indexed for MEDLINE]

244: Masaoka Y, Inoue M, Homma I, Kawamura M.
[Olfactory disorder primarily observed in Parkinson's disease]
No To Shinkei. 2006 Sep;58(9):731-7. Review. Japanese. No abstract available.
PMID: 17051999 [PubMed - indexed for MEDLINE]

245: Truong DD, Jost WH.
Botulinum toxin: clinical use.
Parkinsonism Relat Disord. 2006 Sep;12(6):331-55. Epub 2006 Jul 25. Review.
PMID: 16870487 [PubMed - indexed for MEDLINE]

246: Hurley MJ, Jenner P.
What has been learnt from study of dopamine receptors in Parkinson's disease?
Pharmacol Ther. 2006 Sep;111(3):715-28. Epub 2006 Feb 3. Review.
PMID: 16458973 [PubMed - indexed for MEDLINE]

247: Sakai T, Fukui K.
[Nucling, a novel mediator for cell death pathway]
Seikagaku. 2006 Sep;78(9):867-71. Review. Japanese. No abstract available.
PMID: 17052022 [PubMed - indexed for MEDLINE]

248: Whitnall M, Richardson DR.
Iron: a new target for pharmacological intervention in neurodegenerative
diseases.
Semin Pediatr Neurol. 2006 Sep;13(3):186-97. Review.
PMID: 17101458 [PubMed - indexed for MEDLINE]

249: Gotti C, Zoli M, Clementi F.
Brain nicotinic acetylcholine receptors: native subtypes and their relevance.
Trends Pharmacol Sci. 2006 Sep;27(9):482-91. Epub 2006 Jul 31. Review.
PMID: 16876883 [PubMed - indexed for MEDLINE]

250: Kim YS, Joh TH.
Microglia, major player in the brain inflammation: their roles in the
pathogenesis of Parkinson's disease.
Exp Mol Med. 2006 Aug 31;38(4):333-47. Review.
PMID: 16953112 [PubMed - indexed for MEDLINE]

251: Lashuel HA, Hirling H.
Rescuing defective vesicular trafficking protects against alpha-synuclein
toxicity in cellular and animal models of Parkinson's disease.
ACS Chem Biol. 2006 Aug 22;1(7):420-4. Review.
PMID: 17168518 [PubMed - indexed for MEDLINE]

252: Szeto HH.
Mitochondria-targeted peptide antioxidants: novel neuroprotective agents.
AAPS J. 2006 Aug 18;8(3):E521-31. Review.
PMID: 17025271 [PubMed - indexed for MEDLINE]

253: Castro-García A, Sesar-Ignacio A, Ares-Pensado B, Relova-Quinteiro JL,
Gelabert-González M, Rumbo RM, Noya-García M.
[Psychiatric and cognitive complications arising from subthalamic stimulation in
Parkinson's disease]
Rev Neurol. 2006 Aug 16-31;43(4):218-22. Review. Spanish.
PMID: 16883511 [PubMed - indexed for MEDLINE]

254: Noble C.
Modes of drug delivery used to manage Parkinson's disease.
Nurs Times. 2006 Aug 8-14;102(32):30-2. Review.
PMID: 16922099 [PubMed - indexed for MEDLINE]

255: Galvin JE.
Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of
Parkinson's disease: a case for the selective vulnerability of the substantia
nigra.
Acta Neuropathol. 2006 Aug;112(2):115-26. Epub 2006 Jun 22. Review.
PMID: 16791599 [PubMed - indexed for MEDLINE]

256: Mauceli G, Busceti CI, Pellegrini A, Soldani P, Lenzi P, Paparelli A, Fornai
F.
Overexpression of alpha-synuclein following methamphetamine: is it good or bad?
Ann N Y Acad Sci. 2006 Aug;1074:191-7. Review.
PMID: 17105917 [PubMed - indexed for MEDLINE]

257: Buneeva OA, Medvedev AE.
Ubiquitin-protein ligase parkin and its role in the development of Parkinson's
disease.
Biochemistry (Mosc). 2006 Aug;71(8):851-60. Review.
PMID: 16978147 [PubMed - indexed for MEDLINE]

258: Plunkett K, Bandelow S.
Stochastic approaches to understanding dissociations in inflectional morphology.
Brain Lang. 2006 Aug;98(2):194-209. Epub 2006 Jun 5. Review.
PMID: 16737734 [PubMed - indexed for MEDLINE]

259: Kvernmo T, Härtter S, Burger E.
A review of the receptor-binding and pharmacokinetic properties of dopamine
agonists.
Clin Ther. 2006 Aug;28(8):1065-78. Review.
PMID: 16982285 [PubMed - indexed for MEDLINE]

260: van Eimeren T, Siebner HR.
An update on functional neuroimaging of parkinsonism and dystonia.
Curr Opin Neurol. 2006 Aug;19(4):412-9. Review.
PMID: 16914982 [PubMed - indexed for MEDLINE]

261: Amer DA, Irvine GB, El-Agnaf OM.
Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic
strategy for Parkinson's disease and related disorders.
Exp Brain Res. 2006 Aug;173(2):223-33. Epub 2006 May 30. Review.
PMID: 16733698 [PubMed - indexed for MEDLINE]

262: Melrose HL, Lincoln SJ, Tyndall GM, Farrer MJ.
Parkinson's disease: a rethink of rodent models.
Exp Brain Res. 2006 Aug;173(2):196-204. Epub 2006 Apr 26. Review.
PMID: 16639500 [PubMed - indexed for MEDLINE]

263: Van der Schyf CJ, Gal S, Geldenhuys WJ, Youdim MB.
Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition,
iron chelation, adenosine receptors, and cholinergic and glutamatergic action for
neurodegenerative diseases.
Expert Opin Investig Drugs. 2006 Aug;15(8):873-86. Review.
PMID: 16859391 [PubMed - indexed for MEDLINE]

264: Weydt P, La Spada AR.
Targeting protein aggregation in neurodegeneration--lessons from polyglutamine
disorders.
Expert Opin Ther Targets. 2006 Aug;10(4):505-13. Review.
PMID: 16848688 [PubMed - indexed for MEDLINE]

265: Diamond A, Jankovic J.
Treatment of advanced Parkinson's disease.
Expert Rev Neurother. 2006 Aug;6(8):1181-97. Review.
PMID: 16893346 [PubMed - indexed for MEDLINE]

266: Pathak A, Senard JM.
Blood pressure disorders during Parkinson's disease: epidemiology,
pathophysiology and management.
Expert Rev Neurother. 2006 Aug;6(8):1173-80. Review.
PMID: 16893345 [PubMed - indexed for MEDLINE]

267: Shadrina MI, Slominskiĭ PA.
[Molecular genetics of Parkinson's disease]
Genetika. 2006 Aug;42(8):1045-59. Review. Russian.
PMID: 17025154 [PubMed - indexed for MEDLINE]

268: Chan JM, Feraco A, Shuman M, Hernández-Díaz S.
The epidemiology of prostate cancer--with a focus on nonsteroidal
anti-inflammatory drugs.
Hematol Oncol Clin North Am. 2006 Aug;20(4):797-809. Review.
PMID: 16861115 [PubMed - indexed for MEDLINE]

269: Waza M, Adachi H, Katsuno M, Minamiyama M, Tanaka F, Doyu M, Sobue G.
Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted
therapy against disease-causing protein.
J Mol Med. 2006 Aug;84(8):635-46. Epub 2006 Jun 2. Review.
PMID: 16741751 [PubMed - indexed for MEDLINE]

270: Schulenborg T, Schmidt O, van Hall A, Meyer HE, Hamacher M, Marcus K.
Proteomics in neurodegeneration--disease driven approaches.
J Neural Transm. 2006 Aug;113(8):1055-73. Epub 2006 Jul 13. Review.
PMID: 16835692 [PubMed - indexed for MEDLINE]

271: Bauer M, Ueffing M.
Reverse genetics for proteomics: from proteomic discovery to scientific content.
J Neural Transm. 2006 Aug;113(8):1033-40. Epub 2006 Jul 13. Review.
PMID: 16835688 [PubMed - indexed for MEDLINE]

272: Ward C.
Characteristics and symptom management of progressive supranuclear palsy: a
multidisciplinary approach.
J Neurosci Nurs. 2006 Aug;38(4):242-7. Review.
PMID: 16925000 [PubMed - indexed for MEDLINE]

273: Moser SS, Besler-Panos W.
Pharmacotherapy for Parkinson's disease: current options, promising future
therapies.
JAAPA. 2006 Aug;19(8):38-44. Review. No abstract available.
PMID: 16918085 [PubMed - indexed for MEDLINE]

274: Olanow CW, Obeso JA, Stocchi F.
Continuous dopamine-receptor treatment of Parkinson's disease: scientific
rationale and clinical implications.
Lancet Neurol. 2006 Aug;5(8):677-87. Review.
PMID: 16857573 [PubMed - indexed for MEDLINE]

275: Ishihara L, Brayne C.
What is the evidence for a premorbid parkinsonian personality: a systematic
review.
Mov Disord. 2006 Aug;21(8):1066-72. Review.
PMID: 16755553 [PubMed - indexed for MEDLINE]

276: Hasegawa K.
[Familial Parkinsonism]
No To Shinkei. 2006 Aug;58(8):671-80. Review. Japanese. No abstract available.
PMID: 16986673 [PubMed - indexed for MEDLINE]

277: Sata S.
[Regulation of parkin and Parkinson's disease]
Tanpakushitsu Kakusan Koso. 2006 Aug;51(10 Suppl):1418-22. Review. Japanese. No
abstract available.
PMID: 16922411 [PubMed - indexed for MEDLINE]

278: Tashiro Y, Takahashi R.
[Ubiquitin and Parkinson's disease]
Tanpakushitsu Kakusan Koso. 2006 Aug;51(10 Suppl):1413-7. Review. Japanese. No
abstract available.
PMID: 16922410 [PubMed - indexed for MEDLINE]

279: Matsuda N.
[Overview: hereditary disorders caused by dysfunction of ubiquitylation]
Tanpakushitsu Kakusan Koso. 2006 Aug;51(10 Suppl):1402-7. Review. Japanese. No
abstract available.
PMID: 16922408 [PubMed - indexed for MEDLINE]

280: Walker LC, Levine H 3rd, Mattson MP, Jucker M.
Inducible proteopathies.
Trends Neurosci. 2006 Aug;29(8):438-43. Epub 2006 Jun 27. Review.
PMID: 16806508 [PubMed - indexed for MEDLINE]

281: Goecker D, Rösing D, Beier KM.
[Influence of neurological diseases on partnership and sexuality. Particularly in
view of multiple sclerosis and Parkinson's disease]
Urologe A. 2006 Aug;45(8):992, 994-8. Review. German.
PMID: 16810499 [PubMed - indexed for MEDLINE]

282: Widdicombe J, Eccles R, Fontana G.
Supramedullary influences on cough.
Respir Physiol Neurobiol. 2006 Jul 28;152(3):320-8. Epub 2006 Apr 18. Review.
PMID: 16621735 [PubMed - indexed for MEDLINE]

283: Leiva-Santana C, Alvarez-Saúco M.
[Levodopa and cognitive disorders in Parkinson's disease]
Rev Neurol. 2006 Jul 16-31;43(2):95-100. Review. Spanish.
PMID: 16838257 [PubMed - indexed for MEDLINE]

284: Nakabeppu Y, Kajitani K, Sakamoto K, Yamaguchi H, Tsuchimoto D.
MTH1, an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and
neurotoxicity of oxidized purine nucleotides.
DNA Repair (Amst). 2006 Jul 13;5(7):761-72. Epub 2006 Apr 18. Review.
PMID: 16621731 [PubMed - indexed for MEDLINE]

285: Pálfi M, Szökó E, Kálmán M.
[Molecular mechanisms of the neuroprotective effect of (-)-deprenyl]
Orv Hetil. 2006 Jul 9;147(27):1251-7. Review. Hungarian.
PMID: 16927880 [PubMed - indexed for MEDLINE]

286: Thanvi B, Lo N, Robinson T.
Essential tremor-the most common movement disorder in older people.
Age Ageing. 2006 Jul;35(4):344-9. Epub 2006 Apr 26. Review.
PMID: 16641144 [PubMed - indexed for MEDLINE]

287: Menzies FM, Ravikumar B, Rubinsztein DC.
Protective roles for induction of autophagy in multiple proteinopathies.
Autophagy. 2006 Jul-Sep;2(3):224-5. Epub 2006 Jul 10. Review.
PMID: 16874096 [PubMed - indexed for MEDLINE]

288: Chudasama Y, Robbins TW.
Functions of frontostriatal systems in cognition: comparative
neuropsychopharmacological studies in rats, monkeys and humans.
Biol Psychol. 2006 Jul;73(1):19-38. Epub 2006 Mar 20. Review.
PMID: 16546312 [PubMed - indexed for MEDLINE]

289: Linazasoro G.
Rate of progression determines the clinical outcome after neural transplantation
in Parkinson's disease.
Brain. 2006 Jul;129(Pt 7):E48; author reply E49. Review. No abstract available.
PMID: 16803834 [PubMed - indexed for MEDLINE]

290: Cooke SF, Bliss TV.
Plasticity in the human central nervous system.
Brain. 2006 Jul;129(Pt 7):1659-73. Epub 2006 May 3. Review.
PMID: 16672292 [PubMed - indexed for MEDLINE]

291: Frank C, Pari G, Rossiter JP.
Approach to diagnosis of Parkinson disease.
Can Fam Physician. 2006 Jul;52:862-8. Review.
PMID: 16893149 [PubMed - indexed for MEDLINE]

292: Goldstein DS, Eisenhofer G, Kopin IJ.
Clinical catecholamine neurochemistry: a legacy of Julius Axelrod.
Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):695-702. Epub 2006 Jul 27. Review.
PMID: 16871444 [PubMed - indexed for MEDLINE]

293: Nagatsu T, Sawada M.
Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative
genes, and inflammatory cytokines.
Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):781-802. Epub 2006 Jul 6. Review.
PMID: 16823625 [PubMed - indexed for MEDLINE]

294: Alsasua del Valle A.
Implication of cannabinoids in neurological diseases.
Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):579-91. Epub 2006 May 12. Review.
PMID: 16699878 [PubMed - indexed for MEDLINE]

295: Levy R, Dubois B.
Apathy and the functional anatomy of the prefrontal cortex-basal ganglia
circuits.
Cereb Cortex. 2006 Jul;16(7):916-28. Epub 2005 Oct 5. Review.
PMID: 16207933 [PubMed - indexed for MEDLINE]

296: Nakagawa K.
[Effect of vitamin D on the nervous system and the skeletal muscle]
Clin Calcium. 2006 Jul;16(7):1182-87. Review. Japanese.
PMID: 16816479 [PubMed - indexed for MEDLINE]

297: Borek LL, Amick MM, Friedman JH.
Non-motor aspects of Parkinson's disease.
CNS Spectr. 2006 Jul;11(7):541-54. Review.
PMID: 16816793 [PubMed - indexed for MEDLINE]

298: Skidmore FM, Rodriguez RL, Fernandez HH, Goodman WK, Foote KD, Okun MS.
Lessons learned in deep brain stimulation for movement and neuropsychiatric
disorders.
CNS Spectr. 2006 Jul;11(7):521-36. Review.
PMID: 16816792 [PubMed - indexed for MEDLINE]

299: Waller EA, Kaplan J.
Pergolide-associated valvular heart disease.
Compr Ther. 2006 Summer;32(2):94-101. Review.
PMID: 16845152 [PubMed - indexed for MEDLINE]

300: Weintraub D, Potenza MN.
Impulse control disorders in Parkinson's disease.
Curr Neurol Neurosci Rep. 2006 Jul;6(4):302-6. Review.
PMID: 16822350 [PubMed - indexed for MEDLINE]

301: Siderowf A, Stern MB.
Preclinical diagnosis of Parkinson's disease: are we there yet?
Curr Neurol Neurosci Rep. 2006 Jul;6(4):295-301. Review.
PMID: 16822349 [PubMed - indexed for MEDLINE]

302: Haugarvoll K, Wszolek ZK.
PARK8 LRRK2 parkinsonism.
Curr Neurol Neurosci Rep. 2006 Jul;6(4):287-94. Review.
PMID: 16822348 [PubMed - indexed for MEDLINE]

303: Roberts C.
ACP-103, a 5-HT2A receptor inverse agonist.
Curr Opin Investig Drugs. 2006 Jul;7(7):653-60. Review.
PMID: 16869120 [PubMed - indexed for MEDLINE]

304: Stocchi F.
The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic
considerations.
Expert Opin Pharmacother. 2006 Jul;7(10):1399-407. Review.
PMID: 16805724 [PubMed - indexed for MEDLINE]

305: Onyango I, Khan S, Miller B, Swerdlow R, Trimmer P, Bennett P Jr.
Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's
disease.
J Alzheimers Dis. 2006 Jul;9(2):183-93. Review.
PMID: 16873965 [PubMed - indexed for MEDLINE]

306: Savitt JM, Dawson VL, Dawson TM.
Diagnosis and treatment of Parkinson disease: molecules to medicine.
J Clin Invest. 2006 Jul;116(7):1744-54. Review.
PMID: 16823471 [PubMed - indexed for MEDLINE]

307: St-Gelais F, Jomphe C, Trudeau LE.
The role of neurotensin in central nervous system pathophysiology: what is the
evidence?
J Psychiatry Neurosci. 2006 Jul;31(4):229-45. Review.
PMID: 16862241 [PubMed - indexed for MEDLINE]

308: Schapira AH.
Mitochondrial disease.
Lancet. 2006 Jul 1;368(9529):70-82. Review.
PMID: 16815381 [PubMed - indexed for MEDLINE]

309: Subramony JA.
Apomorphine in dopaminergic therapy.
Mol Pharm. 2006 Jul-Aug;3(4):380-5. Review.
PMID: 16889431 [PubMed - indexed for MEDLINE]

310: Kubo S, Hattori N, Mizuno Y.
Recessive Parkinson's disease.
Mov Disord. 2006 Jul;21(7):885-93. Review.
PMID: 16615060 [PubMed - indexed for MEDLINE]

311: Jankovic J.
An update on the treatment of Parkinson's disease.
Mt Sinai J Med. 2006 Jul;73(4):682-9. Review.
PMID: 16878274 [PubMed - indexed for MEDLINE]

312: Olanow CW, Obeso JA, Stocchi F.
Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's
disease.
Nat Clin Pract Neurol. 2006 Jul;2(7):382-92. Review.
PMID: 16932589 [PubMed - indexed for MEDLINE]

313: Sundararajan S, Jiang Q, Heneka M, Landreth G.
PPARgamma as a therapeutic target in central nervous system diseases.
Neurochem Int. 2006 Jul;49(2):136-44. Epub 2006 Jun 12. Review.
PMID: 16766086 [PubMed - indexed for MEDLINE]

314: Drew PD, Xu J, Storer PD, Chavis JA, Racke MK.
Peroxisome proliferator-activated receptor agonist regulation of glial
activation: relevance to CNS inflammatory disorders.
Neurochem Int. 2006 Jul;49(2):183-9. Epub 2006 Jun 5. Review.
PMID: 16753239 [PubMed - indexed for MEDLINE]

315: Silver D.
Impact of functional age on the use of dopamine agonists in patients with
Parkinson disease.
Neurologist. 2006 Jul;12(4):214-23. Review.
PMID: 16832240 [PubMed - indexed for MEDLINE]

316: Miller RM, Federoff HJ.
Microarrays in Parkinson's disease: a systematic approach.
NeuroRx. 2006 Jul;3(3):319-26. Review.
PMID: 16815215 [PubMed - indexed for MEDLINE]

317: Alasia DD, Asekomeh GA, Unachuku CN.
Parkinsonism induced by sepsis: a case report.
Niger J Med. 2006 Jul-Sep;15(3):333-6. Review.
PMID: 17111773 [PubMed - indexed for MEDLINE]

318: Hanakawa T, Honda M.
[The neural mechanisms underlying "smart brains"]
No To Shinkei. 2006 Jul;58(7):583-92. Review. Japanese. No abstract available.
PMID: 16910467 [PubMed - indexed for MEDLINE]

319: Juri C C, Chaná C P.
[Levodopa for Parkinson's disease: What have we learned?]
Rev Med Chil. 2006 Jul;134(7):893-901. Epub 2006 Aug 29. Review. Spanish.
PMID: 17130974 [PubMed - indexed for MEDLINE]

320: Weiner WJ.
Motor fluctuations in Parkinson's disease.
Rev Neurol Dis. 2006 Summer;3(3):101-8. Review.
PMID: 17047575 [PubMed - indexed for MEDLINE]

321: Vasina V, Barbara G, Talamonti L, Stanghellini V, Corinaldesi R, Tonini M,
De Ponti F, De Giorgio R.
Enteric neuroplasticity evoked by inflammation.
Auton Neurosci. 2006 Jun 30;126-127:264-72. Epub 2006 Apr 19. Review.
PMID: 16624634 [PubMed - indexed for MEDLINE]

322: Lindvall O, Kokaia Z.
Stem cells for the treatment of neurological disorders.
Nature. 2006 Jun 29;441(7097):1094-6. Review.
PMID: 16810245 [PubMed - indexed for MEDLINE]

323: Rasmussen VG, Dupont E, Østergaard K, Egeblad H.
[Valvular heart disease associated with the treatment of Parkinson disease]
Ugeskr Laeger. 2006 Jun 26;168(26-32):2542-4. Review. Danish.
PMID: 16824407 [PubMed - indexed for MEDLINE]

324: Porcel J, Montalban X.
Anticholinesterasics in the treatment of cognitive impairment in multiple
sclerosis.
J Neurol Sci. 2006 Jun 15;245(1-2):177-81. Epub 2006 May 3. Review.
PMID: 16674980 [PubMed - indexed for MEDLINE]

325: Landau W.
What is the risk of sham surgery in Parkinson disease clinical trials? A review
of published reports.
Neurology. 2006 Jun 13;66(11):1788-9; author reply 1788-9. Review. No abstract
available.
PMID: 16769977 [PubMed - indexed for MEDLINE]

326: Hara H.
[Amyloid-beta protein vaccine therapy for alzheimer's disease]
Nippon Naika Gakkai Zasshi. 2006 Jun 10;95(6):1122-8. Review. Japanese. No
abstract available.
PMID: 16846064 [PubMed - indexed for MEDLINE]

327: Chancellor MB, Anderson RU, Boone TB.
Pharmacotherapy for neurogenic detrusor overactivity.
Am J Phys Med Rehabil. 2006 Jun;85(6):536-45. Review.
PMID: 16715024 [PubMed - indexed for MEDLINE]

328: Nowak DA, Hermsdörfer J.
Objective evaluation of manual performance deficits in neurological movement
disorders.
Brain Res Rev. 2006 Jun;51(1):108-24. Epub 2005 Dec 13. Review.
PMID: 16356552 [PubMed - indexed for MEDLINE]

329: Gaggelli E, Kozlowski H, Valensin D, Valensin G.
Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and
Parkinson's diseases and amyotrophic lateral sclerosis).
Chem Rev. 2006 Jun;106(6):1995-2044. Review. No abstract available.
PMID: 16771441 [PubMed - indexed for MEDLINE]

330: Lewis MM, Huang X, Nichols DE, Mailman RB.
D1 and functionally selective dopamine agonists as neuroprotective agents in
Parkinson's disease.
CNS Neurol Disord Drug Targets. 2006 Jun;5(3):345-53. Review.
PMID: 16787233 [PubMed - indexed for MEDLINE]

331: Cooper RN, Butler-Browne GS, Mouly V.
Human muscle stem cells.
Curr Opin Pharmacol. 2006 Jun;6(3):295-300. Epub 2006 Mar 24. Review.
PMID: 16563864 [PubMed - indexed for MEDLINE]

332: Gosal D, Ross OA, Toft M.
Parkinson's disease: the genetics of a heterogeneous disorder.
Eur J Neurol. 2006 Jun;13(6):616-27. Review.
PMID: 16796586 [PubMed - indexed for MEDLINE]

333: Temel Y, Visser-Vandewalle V.
Targets for deep brain stimulation in Parkinson's disease.
Expert Opin Ther Targets. 2006 Jun;10(3):355-62. Review.
PMID: 16706676 [PubMed - indexed for MEDLINE]

334: Dorsey ER, Holloway RG, Ravina BM.
Biomarkers in Parkinson's disease.
Expert Rev Neurother. 2006 Jun;6(6):823-31. Review.
PMID: 16784406 [PubMed - indexed for MEDLINE]

335: Arai H, Furuya T, Mizuno Y, Mochizuki H.
Inflammation and infection in Parkinson's disease.
Histol Histopathol. 2006 Jun;21(6):673-8. Review.
PMID: 16528677 [PubMed - indexed for MEDLINE]

336: Kamat JP.
Peroxynitrite: a potent oxidizing and nitrating agent.
Indian J Exp Biol. 2006 Jun;44(6):436-47. Review.
PMID: 16784114 [PubMed - indexed for MEDLINE]

337: Weiller C, May A, Sach M, Buhmann C, Rijntjes M.
Role of functional imaging in neurological disorders.
J Magn Reson Imaging. 2006 Jun;23(6):840-50. Review.
PMID: 16649207 [PubMed - indexed for MEDLINE]

338: Fasano M, Bergamasco B, Lopiano L.
Is neuromelanin changed in Parkinson's disease? Investigations by magnetic
spectroscopies.
J Neural Transm. 2006 Jun;113(6):769-74. Epub 2006 May 12. Review.
PMID: 16755381 [PubMed - indexed for MEDLINE]

339: Double KL.
Functional effects of neuromelanin and synthetic melanin in model systems.
J Neural Transm. 2006 Jun;113(6):751-6. Epub 2006 May 5. Review.
PMID: 16755379 [PubMed - indexed for MEDLINE]

340: Benmoyal-Segal L, Soreq H.
Gene-environment interactions in sporadic Parkinson's disease.
J Neurochem. 2006 Jun;97(6):1740-55. Review.
PMID: 16805780 [PubMed - indexed for MEDLINE]

341: Kwong JQ, Beal MF, Manfredi G.
The role of mitochondria in inherited neurodegenerative diseases.
J Neurochem. 2006 Jun;97(6):1659-75. Review.
PMID: 16805775 [PubMed - indexed for MEDLINE]

342: Chen HS, Lipton SA.
The chemical biology of clinically tolerated NMDA receptor antagonists.
J Neurochem. 2006 Jun;97(6):1611-26. Review.
PMID: 16805772 [PubMed - indexed for MEDLINE]

343: Rock RB, Peterson PK.
Microglia as a pharmacological target in infectious and inflammatory diseases of
the brain.
J Neuroimmune Pharmacol. 2006 Jun;1(2):117-26. Review.
PMID: 18040778 [PubMed - indexed for MEDLINE]

344: Grimble RF.
The effects of sulfur amino acid intake on immune function in humans.
J Nutr. 2006 Jun;136(6 Suppl):1660S-1665S. Review.
PMID: 16702336 [PubMed - indexed for MEDLINE]

345: Laihinen A, Halsband U.
PET imaging of the basal ganglia.
J Physiol Paris. 2006 Jun;99(4-6):406-13. Epub 2006 May 24. Review.
PMID: 16723212 [PubMed - indexed for MEDLINE]

346: de Lau LM, Breteler MM.
Epidemiology of Parkinson's disease.
Lancet Neurol. 2006 Jun;5(6):525-35. Review.
PMID: 16713924 [PubMed - indexed for MEDLINE]

347: Zanetti R, Loria D, Rosso S.
Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of
the literature.
Melanoma Res. 2006 Jun;16(3):201-6. Review.
PMID: 16718266 [PubMed - indexed for MEDLINE]

348: Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE,
Deuschl G.
Subthalamic nucleus deep brain stimulation: summary and meta-analysis of
outcomes.
Mov Disord. 2006 Jun;21 Suppl 14:S290-304. Review.
PMID: 16892449 [PubMed - indexed for MEDLINE]

349: Gross RE, Krack P, Rodriguez-Oroz MC, Rezai AR, Benabid AL.
Electrophysiological mapping for the implantation of deep brain stimulators for
Parkinson's disease and tremor.
Mov Disord. 2006 Jun;21 Suppl 14:S259-83. Review.
PMID: 16810720 [PubMed - indexed for MEDLINE]

350: Deuschl G, Herzog J, Kleiner-Fisman G, Kubu C, Lozano AM, Lyons KE,
Rodriguez-Oroz MC, Tamma F, Tröster AI, Vitek JL, Volkmann J, Voon V.
Deep brain stimulation: postoperative issues.
Mov Disord. 2006 Jun;21 Suppl 14:S219-37.
PMID: 16810719 [PubMed - indexed for MEDLINE]

351: Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, Ondo W, Pahwa R,
Poewe W, Tröster AI, Uitti R, Voon V.
Deep brain stimulation: preoperative issues.
Mov Disord. 2006 Jun;21 Suppl 14:S171-96.
PMID: 16810718 [PubMed - indexed for MEDLINE]

352: Voon V, Kubu C, Krack P, Houeto JL, Tröster AI.
Deep brain stimulation: neuropsychological and neuropsychiatric issues.
Mov Disord. 2006 Jun;21 Suppl 14:S305-27. Review.
PMID: 16810676 [PubMed - indexed for MEDLINE]

353: Rezai AR, Kopell BH, Gross RE, Vitek JL, Sharan AD, Limousin P, Benabid AL.
Deep brain stimulation for Parkinson's disease: surgical issues.
Mov Disord. 2006 Jun;21 Suppl 14:S197-218.
PMID: 16810673 [PubMed - indexed for MEDLINE]

354: Winge K, Fowler CJ.
Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and
management.
Mov Disord. 2006 Jun;21(6):737-45. Review.
PMID: 16570299 [PubMed - indexed for MEDLINE]

355: Anderson WS, Lenz FA.
Surgery insight: Deep brain stimulation for movement disorders.
Nat Clin Pract Neurol. 2006 Jun;2(6):310-20. Review.
PMID: 16932575 [PubMed - indexed for MEDLINE]

356: Temel Y, Kessels A, Tan S, Topdag A, Boon P, Visser-Vandewalle V.
Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson
disease: a systematic review.
Parkinsonism Relat Disord. 2006 Jun;12(5):265-72. Epub 2006 Apr 18. Review.
PMID: 16621661 [PubMed - indexed for MEDLINE]

357: Obering CD, Chen JJ, Swope DM.
Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in
Parkinson's disease.
Pharmacotherapy. 2006 Jun;26(6):840-52. Review.
PMID: 16716137 [PubMed - indexed for MEDLINE]

358: Brunton S.
A comprehensive approach to Parkinson's disease. How to manage fluctuating motor
and nonmotor symptoms.
Postgrad Med. 2006 Jun-Jul;119(1):55-64. Review.
PMID: 16913648 [PubMed - indexed for MEDLINE]

359: Corvol JC, Girault JA, Hervé D.
[Role and regulation of dopamine D1 receptors in the striatum: implications for
the genesis of dyskinesia in Parkinson's disease]
Rev Neurol (Paris). 2006 Jun;162(6-7):691-702. Review. French.
PMID: 16840977 [PubMed - indexed for MEDLINE]

360: Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K.
Epidemiology of restless legs syndrome: the current status.
Sleep Med Rev. 2006 Jun;10(3):153-67. Review.
PMID: 16762806 [PubMed - indexed for MEDLINE]

361: Tan JM, Dawson TM.
Parkin blushed by PINK1.
Neuron. 2006 May 18;50(4):527-9. Review.
PMID: 16701203 [PubMed - indexed for MEDLINE]

362: Chen JJ, Ly AV.
Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the
treatment of Parkinson's disease.
Am J Health Syst Pharm. 2006 May 15;63(10):915-28. Review.
PMID: 16675649 [PubMed - indexed for MEDLINE]

363: Cropley VL, Fujita M, Innis RB, Nathan PJ.
Molecular imaging of the dopaminergic system and its association with human
cognitive function.
Biol Psychiatry. 2006 May 15;59(10):898-907. Review.
PMID: 16682268 [PubMed - indexed for MEDLINE]

364: Brooks DJ, Piccini P.
Imaging in Parkinson's disease: the role of monoamines in behavior.
Biol Psychiatry. 2006 May 15;59(10):908-18. Epub 2006 Apr 11. Review.
PMID: 16581032 [PubMed - indexed for MEDLINE]

365: Sarkar D, Fisher PB.
Molecular mechanisms of aging-associated inflammation.
Cancer Lett. 2006 May 8;236(1):13-23. Epub 2005 Jun 22. Review.
PMID: 15978720 [PubMed - indexed for MEDLINE]

366: Lladó A, Gaig C, Molinuevo JL.
[Genetics of prevalent neurodegenerative disorders]
Med Clin (Barc). 2006 May 6;126(17):662-70. Review. Spanish.
PMID: 16759568 [PubMed - indexed for MEDLINE]

367: Shih MC, Hoexter MQ, Andrade LA, Bressan RA.
Parkinson's disease and dopamine transporter neuroimaging: a critical review.
Sao Paulo Med J. 2006 May 4;124(3):168-75. Review.
PMID: 17119698 [PubMed - indexed for MEDLINE]

368: Wider C, Burkhard PR, Sajadi A, Vingerhoets FJ.
[Neuronal death and growth factors: new therapeutic approaches in Parkinson's
disease]
Rev Med Suisse. 2006 May 3;2(64):1158-62. Review. French.
PMID: 16734187 [PubMed - indexed for MEDLINE]

369: Dhawan V, Healy DG, Pal S, Chaudhuri KR.
Sleep-related problems of Parkinson's disease.
Age Ageing. 2006 May;35(3):220-8. Review.
PMID: 16638765 [PubMed - indexed for MEDLINE]

370: Weber CA, Ernst ME.
Antioxidants, supplements, and Parkinson's disease.
Ann Pharmacother. 2006 May;40(5):935-8. Epub 2006 Apr 18. Review.
PMID: 16622156 [PubMed - indexed for MEDLINE]

371: Saha RN, Pahan K.
Regulation of inducible nitric oxide synthase gene in glial cells.
Antioxid Redox Signal. 2006 May-Jun;8(5-6):929-47. Review.
PMID: 16771683 [PubMed - indexed for MEDLINE]

372: Hara MR, Cascio MB, Sawa A.
GAPDH as a sensor of NO stress.
Biochim Biophys Acta. 2006 May;1762(5):502-9. Epub 2006 Mar 9. Review.
PMID: 16574384 [PubMed - indexed for MEDLINE]

373: Schernhammer E, Chen H, Ritz B.
Circulating melatonin levels: possible link between Parkinson's disease and
cancer risk?
Cancer Causes Control. 2006 May;17(4):577-82. Review.
PMID: 16596313 [PubMed - indexed for MEDLINE]

374: Oh SK, Choo AB.
Human embryonic stem cells: technological challenges towards therapy.
Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):489-95. Review.
PMID: 16700884 [PubMed - indexed for MEDLINE]

375: Tatsch K, Ell PJ.
PET and SPECT in common neuropsychiatric disease.
Clin Med. 2006 May-Jun;6(3):259-62. Review. No abstract available.
PMID: 16826858 [PubMed - indexed for MEDLINE]

376: Zesiewicz TA, Wecker L, Sullivan KL, Merlin LR, Hauser RA.
The controversy concerning plasma homocysteine in Parkinson disease patients
treated with levodopa alone or with entacapone: effects of vitamin status.
Clin Neuropharmacol. 2006 May-Jun;29(3):106-11. Review.
PMID: 16772808 [PubMed - indexed for MEDLINE]

377: Patkar AA, Pae CU, Masand PS.
Transdermal selegiline: the new generation of monoamine oxidase inhibitors.
CNS Spectr. 2006 May;11(5):363-75. Review.
PMID: 16641841 [PubMed - indexed for MEDLINE]

378: Rickards H.
Depression in neurological disorders: an update.
Curr Opin Psychiatry. 2006 May;19(3):294-8. Review.
PMID: 16612216 [PubMed - indexed for MEDLINE]

379: Michel V, Yuan Z, Ramsubir S, Bakovic M.
Choline transport for phospholipid synthesis.
Exp Biol Med (Maywood). 2006 May;231(5):490-504. Review.
PMID: 16636297 [PubMed - indexed for MEDLINE]

380: Skipper L, Liu JJ, Tan EK.
Polymorphisms in candidate genes: implications for the current treatment of
Parkinson's disease.
Expert Opin Pharmacother. 2006 May;7(7):849-55. Review.
PMID: 16634708 [PubMed - indexed for MEDLINE]

381: Pereira EA, Aziz TZ.
Surgical insights into Parkinson's disease.
J R Soc Med. 2006 May;99(5):238-44. Review.
PMID: 16672757 [PubMed - indexed for MEDLINE]

382: Gagnon JF, Postuma RB, Mazza S, Doyon J, Montplaisir J.
Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases.
Lancet Neurol. 2006 May;5(5):424-32. Review.
PMID: 16632313 [PubMed - indexed for MEDLINE]

383: Ottens AK, Kobeissy FH, Golden EC, Zhang Z, Haskins WE, Chen SS, Hayes RL,
Wang KK, Denslow ND.
Neuroproteomics in neurotrauma.
Mass Spectrom Rev. 2006 May-Jun;25(3):380-408. Review.
PMID: 16498609 [PubMed - indexed for MEDLINE]

384: Fitsanakis VA, Au C, Erikson KM, Aschner M.
The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid
regulation.
Neurochem Int. 2006 May-Jun;48(6-7):426-33. Epub 2006 Feb 28. Review.
PMID: 16513220 [PubMed - indexed for MEDLINE]

385: Salter BC, Anderson KE, Weiner WJ.
Psychosis in Parkinson's disease: case studies.
Neurol Clin. 2006 May;24(2):363-9. Review.
PMID: 16684637 [PubMed - indexed for MEDLINE]

386: Ceiślak M, Komoszyński M.
[Is the inhibition of adenosine A(2A) receptors an efficient way of Parkinson's
disease treatment?]
Neurol Neurochir Pol. 2006 May-Jun;40(3):219-26. Review. Polish.
PMID: 16794962 [PubMed - indexed for MEDLINE]

387: Zabek M, Sobstyl M.
[Deep brain stimulation in the management of Parkinson's disease]
Neurol Neurochir Pol. 2006 May-Jun;40(3):203-11. Review. Polish.
PMID: 16794960 [PubMed - indexed for MEDLINE]

388: Henderson VW.
The neurology of menopause.
Neurologist. 2006 May;12(3):149-59. Review.
PMID: 16688016 [PubMed - indexed for MEDLINE]

389: Martin CJ.
Manganese neurotoxicity: connecting the dots along the continuum of dysfunction.
Neurotoxicology. 2006 May;27(3):347-9. Epub 2005 Dec 5. Review.
PMID: 16337002 [PubMed - indexed for MEDLINE]

390: Cersosimo MG, Koller WC.
The diagnosis of manganese-induced parkinsonism.
Neurotoxicology. 2006 May;27(3):340-6. Epub 2005 Dec 1. Review.
PMID: 16325915 [PubMed - indexed for MEDLINE]

391: Weiss B.
Economic implications of manganese neurotoxicity.
Neurotoxicology. 2006 May;27(3):362-8. Epub 2005 Jun 3. Review.
PMID: 15936082 [PubMed - indexed for MEDLINE]

392: Nishigaki Y, Fuku N, Tanaka M.
[Mitochondrial dysfunctions and age-associated diseases]
Nippon Ronen Igakkai Zasshi. 2006 May;43(3):274-82. Review. Japanese. No abstract
available.
PMID: 16813073 [PubMed - indexed for MEDLINE]

393: Martignoni E, Tassorelli C, Nappi G.
Cardiovascular dysautonomia as a cause of falls in Parkinson's disease.
Parkinsonism Relat Disord. 2006 May;12(4):195-204. Epub 2006 Apr 18. Review.
PMID: 16621660 [PubMed - indexed for MEDLINE]

394: Wojtal K, Trojnar MK, Czuczwar SJ.
Endogenous neuroprotective factors: neurosteroids.
Pharmacol Rep. 2006 May-Jun;58(3):335-40. Review.
PMID: 16845207 [PubMed - indexed for MEDLINE]

395: Pereira EA, Aziz TZ.
Parkinson's disease and primate research: past, present, and future.
Postgrad Med J. 2006 May;82(967):293-9. Review.
PMID: 16679465 [PubMed - indexed for MEDLINE]

396: Lashuel HA, Lansbury PT Jr.
Are amyloid diseases caused by protein aggregates that mimic bacterial
pore-forming toxins?
Q Rev Biophys. 2006 May;39(2):167-201. Epub 2006 Sep 18. Review.
PMID: 16978447 [PubMed - indexed for MEDLINE]

397: Vivancos-Matellano F.
[Ropinirole in the treatment of Parkinson's disease: an update]
Rev Neurol. 2006 May 1-15;42(9):542-8. Review. Spanish.
PMID: 16676278 [PubMed - indexed for MEDLINE]

398: Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA.
LRRK2 in Parkinson's disease: protein domains and functional insights.
Trends Neurosci. 2006 May;29(5):286-93. Epub 2006 Apr 17. Review.
PMID: 16616379 [PubMed - indexed for MEDLINE]

399: Hershey T, Mink JW.
Using functional neuroimaging to study the brain's response to deep brain
stimulation.
Neurology. 2006 Apr 25;66(8):1142-3. Review. No abstract available.
PMID: 16636228 [PubMed - indexed for MEDLINE]

400: Lo SE, Jain S.
Patient page. Slowing down a "slow" movement disorder: selegiline's benefit in
treating Parkinson disease.
Neurology. 2006 Apr 25;66(8):E28-9. Review. No abstract available.
PMID: 16636224 [PubMed - indexed for MEDLINE]

401: Coggrave M, Wiesel PH, Norton C.
Management of faecal incontinence and constipation in adults with central
neurological diseases.
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002115. Review.
PMID: 16625555 [PubMed - indexed for MEDLINE]

402: Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett
M, Miyasaki J, Stevens J, Weiner WJ; Quality Standards Subcommittee of the
American Academy of Neurology.
Practice Parameter: treatment of Parkinson disease with motor fluctuations and
dyskinesia (an evidence-based review): report of the Quality Standards
Subcommittee of the American Academy of Neurology.
Neurology. 2006 Apr 11;66(7):983-95. Review.
PMID: 16606909 [PubMed - indexed for MEDLINE]

403: Ishihara L, Brayne C.
A systematic review of depression and mental illness preceding Parkinson's
disease.
Acta Neurol Scand. 2006 Apr;113(4):211-20. Review.
PMID: 16542159 [PubMed - indexed for MEDLINE]

404: Neef D, Walling AD.
Dementia with Lewy bodies: an emerging disease.
Am Fam Physician. 2006 Apr 1;73(7):1223-9. Review. Summary for patients in: Am
Fam Physician. 2006 Apr 1;73(7):1230.
PMID: 16623209 [PubMed - indexed for MEDLINE]

405: Langston JW.
The Parkinson's complex: parkinsonism is just the tip of the iceberg.
Ann Neurol. 2006 Apr;59(4):591-6. Review. No abstract available.
PMID: 16566021 [PubMed - indexed for MEDLINE]

406: Sarkar S, Rubinsztein DC.
Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations.
Autophagy. 2006 Apr-Jun;2(2):132-4. Epub 2006 Apr 6. Review.
PMID: 16874097 [PubMed - indexed for MEDLINE]

407: Conti L, Reitano E, Cattaneo E.
Neural stem cell systems: diversities and properties after transplantation in
animal models of diseases.
Brain Pathol. 2006 Apr;16(2):143-54. Review.
PMID: 16768755 [PubMed - indexed for MEDLINE]

408: Roesler R, Henriques JA, Schwartsmann G.
Gastrin-releasing peptide receptor as a molecular target for psychiatric and
neurological disorders.
CNS Neurol Disord Drug Targets. 2006 Apr;5(2):197-204. Review.
PMID: 16611092 [PubMed - indexed for MEDLINE]

409: Morrell M.
Brain stimulation for epilepsy: can scheduled or responsive neurostimulation stop
seizures?
Curr Opin Neurol. 2006 Apr;19(2):164-8. Review.
PMID: 16538091 [PubMed - indexed for MEDLINE]

410: Logemann JA.
Update on clinical trials in Dysphagia.
Dysphagia. 2006 Apr;21(2):116-20. Review.
PMID: 16685468 [PubMed - indexed for MEDLINE]

411: Fountoulakis M, Kossida S.
Proteomics-driven progress in neurodegeneration research.
Electrophoresis. 2006 Apr;27(8):1556-73. Review.
PMID: 16555340 [PubMed - indexed for MEDLINE]

412: Mallet L.
[Profound cerebral stimulation: its usefulness for the therapeutic modulation of
behavior and emotions]
Encephale. 2006 Apr;32(Pt 2):S44-7. Review. French. No abstract available.
PMID: 16910618 [PubMed - indexed for MEDLINE]

413: Balk E, Chung M, Raman G, Tatsioni A, Chew P, Ip S, DeVine D, Lau J.
B vitamins and berries and age-related neurodegenerative disorders.
Evid Rep Technol Assess (Full Rep). 2006 Apr;(134):1-161. Review.
PMID: 17628125 [PubMed - indexed for MEDLINE]

414: Chou KL, Fernandez HH.
Combating psychosis in Parkinson's disease patients: the use of antipsychotic
drugs.
Expert Opin Investig Drugs. 2006 Apr;15(4):339-49. Review.
PMID: 16548784 [PubMed - indexed for MEDLINE]

415: Chaudhuri TK, Paul S.
Protein-misfolding diseases and chaperone-based therapeutic approaches.
FEBS J. 2006 Apr;273(7):1331-49. Review.
PMID: 16689923 [PubMed - indexed for MEDLINE]

416: Singh MP, Patel S, Dikshit M, Gupta YK.
Contribution of genomics and proteomics in understanding the role of modifying
factors in Parkinson's disease.
Indian J Biochem Biophys. 2006 Apr;43(2):69-81. Review.
PMID: 16955754 [PubMed - indexed for MEDLINE]

417: Bittar RG.
Neuromodulation for movement disorders.
J Clin Neurosci. 2006 Apr;13(3):315-8. Epub 2006 Mar 20. Review.
PMID: 16546394 [PubMed - indexed for MEDLINE]

418: Gregersen N.
Protein misfolding disorders: pathogenesis and intervention.
J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):456-70. Review.
PMID: 16763918 [PubMed - indexed for MEDLINE]

419: Papapetropoulos S.
Regional alpha-synuclein aggregation, dopaminergic dysregulation, and the
development of drug-related visual hallucinations in Parkinson's disease.
J Neuropsychiatry Clin Neurosci. 2006 Spring;18(2):149-57. Review.
PMID: 16720791 [PubMed - indexed for MEDLINE]

420: Schrag A, Schott JM.
Epidemiological, clinical, and genetic characteristics of early-onset
parkinsonism.
Lancet Neurol. 2006 Apr;5(4):355-63. Review.
PMID: 16545752 [PubMed - indexed for MEDLINE]

421: Chang VC, Chou KL.
Deep brain stimulation for Parkinson's disease: patient selection and motor
outcomes.
Med Health R I. 2006 Apr;89(4):142-4. Review.
PMID: 16676911 [PubMed - indexed for MEDLINE]

422: Amick MM, Grace J.
Deep brain stimulation surgery for Parkinson's disease: the role of
neuropsychological assessment.
Med Health R I. 2006 Apr;89(4):130-3. Review.
PMID: 16676908 [PubMed - indexed for MEDLINE]

423: Farrer MJ.
Genetics of Parkinson disease: paradigm shifts and future prospects.
Nat Rev Genet. 2006 Apr;7(4):306-18. Review.
PMID: 16543934 [PubMed - indexed for MEDLINE]

424: Lim KL, Dawson VL, Dawson TM.
Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions
formation in Parkinson's and other conformational diseases?
Neurobiol Aging. 2006 Apr;27(4):524-9. Epub 2005 Oct 6. Review.
PMID: 16213628 [PubMed - indexed for MEDLINE]

425: McNaught KS, Olanow CW.
Protein aggregation in the pathogenesis of familial and sporadic Parkinson's
disease.
Neurobiol Aging. 2006 Apr;27(4):530-45. Epub 2005 Oct 3. Review.
PMID: 16207501 [PubMed - indexed for MEDLINE]

426: Tanaka K.
[Impairment of the ubiquitin-proteasome system and neurodegeneration]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2006 Apr;26(2):67-73. Review. Japanese.
PMID: 16722463 [PubMed - indexed for MEDLINE]

427: Maggini M, Vanacore N, Raschetti R.
Cholinesterase inhibitors: drugs looking for a disease?
PLoS Med. 2006 Apr;3(4):e140. Epub 2006 Apr 11. Review. No abstract available.
PMID: 16597173 [PubMed - indexed for MEDLINE]

428: Rao KS, Hegde ML, Anitha S, Musicco M, Zucca FA, Turro NJ, Zecca L.
Amyloid beta and neuromelanin--toxic or protective molecules? The cellular
context makes the difference.
Prog Neurobiol. 2006 Apr;78(6):364-73. Epub 2006 May 8. Review.
PMID: 16682109 [PubMed - indexed for MEDLINE]

429: Monnet-Tschudi F, Zurich MG, Boschat C, Corbaz A, Honegger P.
Involvement of environmental mercury and lead in the etiology of
neurodegenerative diseases.
Rev Environ Health. 2006 Apr-Jun;21(2):105-17. Review.
PMID: 16898674 [PubMed - indexed for MEDLINE]

430: [No authors listed]
A Unique International Event--Bringing the Parkinson's Community Together.
Highlights of the First World Parkinson's Congress, Washington DC, February
22-26, 2006.
Rev Neurol Dis. 2006 Spring;3(2):71-3. Review. No abstract available.
PMID: 16819422 [PubMed - indexed for MEDLINE]

431: Li WW, Cai DF, Ren HM.
[Neurodegenerative conformational disease and its molecular bases]
Sheng Li Ke Xue Jin Zhan. 2006 Apr;37(2):97-102. Review. Chinese.
PMID: 16850610 [PubMed - in process]

432: Zaveri NT.
Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer
applications.
Life Sci. 2006 Mar 27;78(18):2073-80. Epub 2006 Jan 30. Review.
PMID: 16445946 [PubMed - indexed for MEDLINE]

433: Holloway RG Jr, Józefowicz RF.
Update in neurology.
Ann Intern Med. 2006 Mar 21;144(6):421-6. Review. No abstract available.
PMID: 16549854 [PubMed - indexed for MEDLINE]

434: Scott L.
Identifying poor symptom control in Parkinson's disease.
Nurs Times. 2006 Mar 21-27;102(12):30-2. Review.
PMID: 16594560 [PubMed - indexed for MEDLINE]

435: Tilley BC, Palesch YY, Kieburtz K, Ravina B, Huang P, Elm JJ, Shannon K,
Wooten GF, Tanner CM, Goetz GC; NET-PD Investigators.
Optimizing the ongoing search for new treatments for Parkinson disease: using
futility designs.
Neurology. 2006 Mar 14;66(5):628-33. Review.
PMID: 16534099 [PubMed - indexed for MEDLINE]

436: Kim RH, Mak TW.
Tumours and tremors: how PTEN regulation underlies both.
Br J Cancer. 2006 Mar 13;94(5):620-4. Review.
PMID: 16495927 [PubMed - indexed for MEDLINE]

437: Lewin AH.
Receptors of mammalian trace amines.
AAPS J. 2006 Mar 10;8(1):E138-45. Review.
PMID: 16584120 [PubMed - indexed for MEDLINE]

438: Schapira AH, Obeso J.
Timing of treatment initiation in Parkinson's disease: a need for reappraisal?
Ann Neurol. 2006 Mar;59(3):559-62. Review. No abstract available.
PMID: 16489611 [PubMed - indexed for MEDLINE]

439: Galpern WR, Lang AE.
Interface between tauopathies and synucleinopathies: a tale of two proteins.
Ann Neurol. 2006 Mar;59(3):449-58. Review.
PMID: 16489609 [PubMed - indexed for MEDLINE]

440: Klein C.
Implications of genetics on the diagnosis and care of patients with Parkinson
disease.
Arch Neurol. 2006 Mar;63(3):328-34. Review.
PMID: 16533959 [PubMed - indexed for MEDLINE]

441: Silva JL, Cordeiro Y, Foguel D.
Protein folding and aggregation: two sides of the same coin in the condensation
of proteins revealed by pressure studies.
Biochim Biophys Acta. 2006 Mar;1764(3):443-51. Epub 2005 Dec 19. Review.
PMID: 16480935 [PubMed - indexed for MEDLINE]

442: Yoshitake T, Kehr J, Todoroki K, Nohta H, Yamaguchi M.
Derivatization chemistries for determination of serotonin, norepinephrine and
dopamine in brain microdialysis samples by liquid chromatography with
fluorescence detection.
Biomed Chromatogr. 2006 Mar;20(3):267-81. Review.
PMID: 16110472 [PubMed - indexed for MEDLINE]

443: Outeiro TF, Giorgini F.
Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
Biotechnol J. 2006 Mar;1(3):258-69. Review.
PMID: 16897706 [PubMed - indexed for MEDLINE]

444: Lindholm D, Wootz H, Korhonen L.
ER stress and neurodegenerative diseases.
Cell Death Differ. 2006 Mar;13(3):385-92. Review.
PMID: 16397584 [PubMed - indexed for MEDLINE]

445: Rye DB.
Excessive daytime sleepiness and unintended sleep in Parkinson's disease.
Curr Neurol Neurosci Rep. 2006 Mar;6(2):169-76. Review.
PMID: 16522272 [PubMed - indexed for MEDLINE]

446: Nofzinger EA.
Neuroimaging of sleep and sleep disorders.
Curr Neurol Neurosci Rep. 2006 Mar;6(2):149-55. Review.
PMID: 16522269 [PubMed - indexed for MEDLINE]

447: Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L.
[Oxidative stress involvement in schizophrenia pathophysiology: a review]
Encephale. 2006 Mar-Apr;32(2 Pt 1):244-52. Review. French.
PMID: 16910626 [PubMed - indexed for MEDLINE]

448: Shulman LM, Bhat V.
Gender disparities in Parkinson's disease.
Expert Rev Neurother. 2006 Mar;6(3):407-16. Review.
PMID: 16533144 [PubMed - indexed for MEDLINE]

449: Nacimiento W.
[Parkinson-plus-syndromes]
Fortschr Neurol Psychiatr. 2006 Mar;74(3):165-78; quiz 179-80. Review. German. No
abstract available.
PMID: 16528643 [PubMed - indexed for MEDLINE]

450: Manfredsson FP, Lewin AS, Mandel RJ.
RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
Gene Ther. 2006 Mar;13(6):517-24. Review.
PMID: 16267570 [PubMed - indexed for MEDLINE]

451: Bhidayasiri R, Srikijvilaikul T, Locharernkul C, Phanthumchinda K,
Kaoroptham S.
State of the art: deep brain stimulation in Parkinson's disease.
J Med Assoc Thai. 2006 Mar;89(3):390-400. Review.
PMID: 16696426 [PubMed - indexed for MEDLINE]

452: Chaudhuri KR, Healy DG, Schapira AH; National Institute for Clinical
Excellence.
Non-motor symptoms of Parkinson's disease: diagnosis and management.
Lancet Neurol. 2006 Mar;5(3):235-45. Review.
PMID: 16488379 [PubMed - indexed for MEDLINE]

453: Klein C, Schlossmacher MG.
The genetics of Parkinson disease: Implications for neurological care.
Nat Clin Pract Neurol. 2006 Mar;2(3):136-46. Review.
PMID: 16932540 [PubMed - indexed for MEDLINE]

454: Abou-Sleiman PM, Muqit MM, Wood NW.
Expanding insights of mitochondrial dysfunction in Parkinson's disease.
Nat Rev Neurosci. 2006 Mar;7(3):207-19. Review.
PMID: 16495942 [PubMed - indexed for MEDLINE]

455: Padovani A, Costanzi C, Gilberti N, Borroni B.
Parkinson's disease and dementia.
Neurol Sci. 2006 Mar;27 Suppl 1:S40-3. Review.
PMID: 16708183 [PubMed - indexed for MEDLINE]

456: Natsume A.
[Herpes vector-mediated gene therapy]
Nippon Rinsho. 2006 Mar;64 Suppl 3:361-5. Review. Japanese. No abstract
available.
PMID: 16615499 [PubMed - indexed for MEDLINE]

457: Miwa H, Okawa M, Kondo T.
[Echogenicity of the substantia nigra in Parkinson's disease: its relation to
clinical findings]
No To Shinkei. 2006 Mar;58(3):199-204. Review. Japanese. No abstract available.
PMID: 16629443 [PubMed - indexed for MEDLINE]

458: Dishman RK, Berthoud HR, Booth FW, Cotman CW, Edgerton VR, Fleshner MR,
Gandevia SC, Gomez-Pinilla F, Greenwood BN, Hillman CH, Kramer AF, Levin BE,
Moran TH, Russo-Neustadt AA, Salamone JD, Van Hoomissen JD, Wade CE, York DA,
Zigmond MJ.
Neurobiology of exercise.
Obesity (Silver Spring). 2006 Mar;14(3):345-56. Review.
PMID: 16648603 [PubMed - indexed for MEDLINE]

459: Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D.
Movement disorders and Creutzfeldt-Jakob disease: a review.
Parkinsonism Relat Disord. 2006 Mar;12(2):65-71. Epub 2005 Dec 20. Review.
PMID: 16364674 [PubMed - indexed for MEDLINE]

460: Fumagalli F, Racagni G, Riva MA.
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's
disease.
Pharmacogenomics J. 2006 Mar-Apr;6(2):95-104. Review.
PMID: 16402079 [PubMed - indexed for MEDLINE]

461: Franke H, Illes P.
Involvement of P2 receptors in the growth and survival of neurons in the CNS.
Pharmacol Ther. 2006 Mar;109(3):297-324. Epub 2005 Aug 15. Review.
PMID: 16102837 [PubMed - indexed for MEDLINE]

462: Ho HY, Li M.
Potential application of embryonic stem cells in Parkinson's disease: drug
screening and cell therapy.
Regen Med. 2006 Mar;1(2):175-82. Review.
PMID: 17465801 [PubMed - indexed for MEDLINE]

463: Bozzi Y, Borrelli E.
Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do
with it?
Trends Neurosci. 2006 Mar;29(3):167-74. Epub 2006 Jan 27. Review.
PMID: 16443286 [PubMed - indexed for MEDLINE]

464: Papatsoris AG, Deliveliotis C, Singer C, Papapetropoulos S.
Erectile dysfunction in Parkinson's disease.
Urology. 2006 Mar;67(3):447-51. Epub 2006 Feb 28. Review. No abstract available.
PMID: 16504269 [PubMed - indexed for MEDLINE]

465: Widdicombe J, Singh V.
Physiological and pathophysiological down-regulation of cough.
Respir Physiol Neurobiol. 2006 Feb 28;150(2-3):105-17. Review.
PMID: 15878697 [PubMed - indexed for MEDLINE]

466: [No authors listed]
Coenzyme Q10.
Med Lett Drugs Ther. 2006 Feb 27;48(1229):19-20. Review. No abstract available.
Erratum in: Med Lett Drugs Ther. 2006 Mar 13;48(1230):24.
PMID: 16498307 [PubMed - indexed for MEDLINE]

467: Lökk J, Winblad B.
[Dementia--common, difficult to treat complication in Parkinson disease. Early
diagnosis valuable--cholinesterase inhibitors can give better quality of life]
Lakartidningen. 2006 Feb 15-21;103(7):451-5. Review. Swedish. No abstract
available.
PMID: 16535872 [PubMed - indexed for MEDLINE]

468: Guo Q.
When good Cdk5 turns bad.
Sci Aging Knowledge Environ. 2006 Feb 8;2006(5):pe5. Review.
PMID: 16469730 [PubMed - indexed for MEDLINE]

469: Fowler CJ.
Integrated control of lower urinary tract--clinical perspective.
Br J Pharmacol. 2006 Feb;147 Suppl 2:S14-24. Review.
PMID: 16465178 [PubMed - indexed for MEDLINE]

470: Brice A.
[What can we learn from genes responsible for familial forms of Parkinson's
disease?]
Bull Acad Natl Med. 2006 Feb;190(2):485-96; discussion 497-8. Review. French.
PMID: 17001874 [PubMed - indexed for MEDLINE]

471: Zadikoff C, Rochon P, Lang A.
Cardiac valvulopathy associated with pergolide use.
Can J Neurol Sci. 2006 Feb;33(1):27-33. Review.
PMID: 16583718 [PubMed - indexed for MEDLINE]

472: Westerink RH.
Targeting exocytosis: ins and outs of the modulation of quantal dopamine release.
CNS Neurol Disord Drug Targets. 2006 Feb;5(1):57-77. Review.
PMID: 16613554 [PubMed - indexed for MEDLINE]

473: Sokoloff P, Diaz J, Le Foll B, Guillin O, Leriche L, Bezard E, Gross C.
The dopamine D3 receptor: a therapeutic target for the treatment of
neuropsychiatric disorders.
CNS Neurol Disord Drug Targets. 2006 Feb;5(1):25-43. Review.
PMID: 16613552 [PubMed - indexed for MEDLINE]

474: Werkman TR, Glennon JC, Wadman WJ, McCreary AC.
Dopamine receptor pharmacology: interactions with serotonin receptors and
significance for the aetiology and treatment of schizophrenia.
CNS Neurol Disord Drug Targets. 2006 Feb;5(1):3-23. Review.
PMID: 16613551 [PubMed - indexed for MEDLINE]

475: Sekine Y, Takeda K, Ichijo H.
The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases.
Curr Mol Med. 2006 Feb;6(1):87-97. Review.
PMID: 16472116 [PubMed - indexed for MEDLINE]

476: Gogas KR.
Glutamate-based therapeutic approaches: NR2B receptor antagonists.
Curr Opin Pharmacol. 2006 Feb;6(1):68-74. Epub 2005 Dec 22. Review.
PMID: 16376149 [PubMed - indexed for MEDLINE]

477: Marino MJ, Conn PJ.
Glutamate-based therapeutic approaches: allosteric modulators of metabotropic
glutamate receptors.
Curr Opin Pharmacol. 2006 Feb;6(1):98-102. Epub 2005 Dec 20. Review.
PMID: 16368268 [PubMed - indexed for MEDLINE]

478: Whitworth AJ, Wes PD, Pallanck LJ.
Drosophila models pioneer a new approach to drug discovery for Parkinson's
disease.
Drug Discov Today. 2006 Feb;11(3-4):119-26. Review.
PMID: 16533709 [PubMed - indexed for MEDLINE]

479: Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS.
Pesticides and Parkinson's disease--is there a link?
Environ Health Perspect. 2006 Feb;114(2):156-64. Review.
PMID: 16451848 [PubMed - indexed for MEDLINE]

480: Tan EK.
Botulinum toxin treatment of sialorrhea: comparing different therapeutic
preparations.
Eur J Neurol. 2006 Feb;13 Suppl 1:60-4. Review.
PMID: 16417600 [PubMed - indexed for MEDLINE]

481: Marin C, Rodriguez-Oroz MC, Obeso JA.
Motor complications in Parkinson's disease and the clinical significance of
rotational behavior in the rat: have we wasted our time?
Exp Neurol. 2006 Feb;197(2):269-74. Epub 2005 Dec 22. Review. No abstract
available.
PMID: 16375892 [PubMed - indexed for MEDLINE]

482: Sheta EA, Appel SH, Goldknopf IL.
2D gel blood serum biomarkers reveal differential clinical proteomics of the
neurodegenerative diseases.
Expert Rev Proteomics. 2006 Feb;3(1):45-62. Review.
PMID: 16445350 [PubMed - indexed for MEDLINE]

483: Stocchi F.
Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's
disease.
Int J Clin Pract. 2006 Feb;60(2):215-21. Review.
PMID: 16451296 [PubMed - indexed for MEDLINE]

484: Fasano M, Bergamasco B, Lopiano L.
Modifications of the iron-neuromelanin system in Parkinson's disease.
J Neurochem. 2006 Feb;96(4):909-16. Epub 2006 Jan 17. Review.
PMID: 16417570 [PubMed - indexed for MEDLINE]

485: Quik M, McIntosh JM.
Striatal alpha6* nicotinic acetylcholine receptors: potential targets for
Parkinson's disease therapy.
J Pharmacol Exp Ther. 2006 Feb;316(2):481-9. Epub 2005 Oct 6. Review.
PMID: 16210393 [PubMed - indexed for MEDLINE]

486: Marsh L, McDonald WM, Cummings J, Ravina B; NINDS/NIMH Work Group on
Depression and Parkinson's Disease.
Provisional diagnostic criteria for depression in Parkinson's disease: report of
an NINDS/NIMH Work Group.
Mov Disord. 2006 Feb;21(2):148-58. Review.
PMID: 16211591 [PubMed - indexed for MEDLINE]

487: Ebersbach G, Poewe W.
[Vascular parkinsonian syndrome]
Nervenarzt. 2006 Feb;77(2):139-44, 146-7. Review. German.
PMID: 16133431 [PubMed - indexed for MEDLINE]

488: Akiyama H.
[Abeta, tau and alpha-synuclein and glial cells]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2006 Feb;26(1):23-31. Review. Japanese.
PMID: 16637593 [PubMed - indexed for MEDLINE]

489: Siniscalchi A, Gallelli L, Mercuri NB, Ibbadu GF, De Sarro G.
Role of lifestyle factors on plasma homocysteine levels in Parkison's disease
patients treated with levodopa.
Nutr Neurosci. 2006 Feb-Apr;9(1-2):11-6. Review.
PMID: 16910165 [PubMed - indexed for MEDLINE]

490: Taylor JP, Mata IF, Farrer MJ.
LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?
Trends Mol Med. 2006 Feb;12(2):76-82. Epub 2006 Jan 10. Review.
PMID: 16406842 [PubMed - indexed for MEDLINE]

491: Berg D, Behnke S, Walter U.
Application of transcranial sonography in extrapyramidal disorders: updated
recommendations.
Ultraschall Med. 2006 Feb;27(1):12-9. Review.
PMID: 16470475 [PubMed - indexed for MEDLINE]

492: Maidment I, Fox C, Boustani M.
Cholinesterase inhibitors for Parkinson's disease dementia.
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004747. Review.
PMID: 16437494 [PubMed - indexed for MEDLINE]

493: Treiber C.
Prion 2005: Between Fundamentals and Society's Needs.
Sci Aging Knowledge Environ. 2006 Jan 25;2006(4):pe4. Review.
PMID: 16436784 [PubMed - indexed for MEDLINE]

494: Glabe CG, Kayed R.
Common structure and toxic function of amyloid oligomers implies a common
mechanism of pathogenesis.
Neurology. 2006 Jan 24;66(2 Suppl 1):S74-8. Review.
PMID: 16432151 [PubMed - indexed for MEDLINE]

495: May BC, Govaerts C, Cohen FE.
Developing therapeutics for the diseases of protein misfolding.
Neurology. 2006 Jan 24;66(2 Suppl 1):S118-22. Review.
PMID: 16432139 [PubMed - indexed for MEDLINE]

496: Scholten WK.
[The mechanism of action of cannabis and cannabinoids]
Ned Tijdschr Geneeskd. 2006 Jan 21;150(3):128-31. Review. Dutch.
PMID: 16463612 [PubMed - indexed for MEDLINE]

497: Moore DJ, Dawson VL, Dawson TM.
Lessons from Drosophila models of DJ-1 deficiency.
Sci Aging Knowledge Environ. 2006 Jan 11;2006(2):pe2. Review.
PMID: 16407572 [PubMed - indexed for MEDLINE]

498: Du Pasquier R, Bogousslavsky J.
[Therapeutical advances in neurology in 2005]
Rev Med Suisse. 2006 Jan 4;2(47):35-40. Review. French.
PMID: 16465943 [PubMed - indexed for MEDLINE]

499: Maruszak A, Gaweda-Walerych K, Sołtyszewski I, Zekanowski C.
Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases.
Acta Neurobiol Exp (Wars). 2006;66(2):153-76. Review.
PMID: 16886726 [PubMed - indexed for MEDLINE]

500: Lieberman A.
Depression in Parkinson's disease -- a review.
Acta Neurol Scand. 2006 Jan;113(1):1-8. Review.
PMID: 16367891 [PubMed - indexed for MEDLINE]

Back to top